Convulsions, not elsewhere classified

R18_CONVU_NOT_ELSEW_CLASSIFIED

No definition available.

Endpoint definition

↥

Endpoint definition steps	FinnGen
Phenotype data	520210
1. Apply sex-specific rule None	520210
2. Check conditions None	520210
3. Check pre-conditions, main-only, mode, registry filters Registry filters: Hospital discharge: ICD-10 — R56 Cause of death: ICD-10 — R56 2 out of 7 registries used, show all original rules.	12451
4. Check minimum number of events None	12451
5. Include endpoints None	12451
6. Filter based on genotype QC (FinnGen only)	12451

Control definitions (FinnGen only)

Control exclude: R18_GENERAL_SYMPTOMS_SIGNS

Extra metadata

Level in the ICD hierarchy: 3
First used in FinnGen datafreeze: DF4
Parent code in ICD-10: R[5-6]
Name in latin: Convulsiones non alibi classificatae

NAME	R18_CONVU_NOT_ELSEW_CLASSIFIED
CONTROL_EXCLUDE	R18_GENERAL_SYMPTOMS_SIGNS
CONTROL_PRECONDITIONS
CONTROL_CONDITIONS
SEX
INCLUDE
PRE_CONDITIONS
CONDITIONS
OUTPAT_ICD
OUTPAT_OPER
HD_MAINONLY
HD_ICD_10_ATC
HD_ICD_10	R56
HD_ICD_9
HD_ICD_8
HD_ICD_10_EXCL
HD_ICD_9_EXCL
HD_ICD_8_EXCL
COD_MAINONLY
COD_ICD_10	R56
COD_ICD_9
COD_ICD_8
COD_ICD_10_EXCL
COD_ICD_9_EXCL
COD_ICD_8_EXCL
OPER_NOM
OPER_HL
OPER_HP1
OPER_HP2
KELA_REIMB
KELA_REIMB_ICD
KELA_ATC_NEEDOTHER
KELA_ATC
KELA_VNRO_NEEDOTHER
KELA_VNRO
CANC_TOPO
CANC_TOPO_EXCL
CANC_MORPH
CANC_MORPH_EXCL
CANC_BEHAV

Similar endpoints

↥

List of similar endpoints to Convulsions, not elsewhere classified based on the number of shared cases.

Similar with more cases:

Similar with less cases:

None

Case counts by codes

↥

FinnGen case counts by registry codes:

Upset plot

Full data table

Summary Statistics

↥

-FinRegistry-

This endpoint is excluded from FinRegistry analyses (omitted endpoint).

-FinnGen-

Key figures

	All	Female	Male
Number of individuals	12451	5800	6651
Unadjusted period prevalence (%)	2.49	1.98	2.93
Median age at first event (years)	46.59	40.24	52.14

-FinnGen-

Age distribution of first events

-FinnGen-

Year distribution of first events

-FinnGen-

Cumulative Incidence Function

Not a core endpoint, no data to show.

CodeWAS (R11)

↥

CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.

This is a new tool, please reach out using the contact form for feedback and improvement ideas.

First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log₁₀(p-value) ≥ 6.

Matched cohort

Matched cases
10995: Matched controls
109326

Code

Vocabulary

Description

Odds Ratio

-log₁₀(p)

N matched cases

N matched controls

R50.9

ICD-10 Finland

Fever, unspecified

7.9

323.0

1494

2138

X69

ICD-10 Finland

Intentional self-poisoning by and exposure to other and unspecified chemicals and noxious substances

9.4

323.0

952

1091

111

Kela drug reimbursment

Epilepsy and comparable convulsive disorders

39.2

323.0

3633

1360

AA1CG

NOMESCO Finland

Extensive MRI examination of brain with high intensity magnet

7.0

323.0

1587

2587

G40.20

ICD-10 Finland

Complex partial seizures with only alteration of consciousness

30.7

323.0

542

184

G40.22

ICD-10 Finland

Complex partial epileptic seizure with secondary generalization

62.4

323.0

1578

293

R55

ICD-10 Finland

Syncope and collapse

42.4

323.0

2062

592

N03AF01

ATC

carbamazepine; oral, rectal

9.7

323.0

1295

1485

R29.8

ICD-10 Finland

Other and unspecified symptoms and signs involving the nervous and musculoskeletal systems

4.9

323.0

1247

2798

AA1AD

NOMESCO Finland

CT of head and brain

7.5

323.0

4479

9141

G40.29

ICD-10 Finland

Localization-related (focal)(partial) symptomatic epilepsy and epileptic syndromes with complex partial seizures

44.6

323.0

1261

316

N03AF02

ATC

oxcarbazepine; oral

37.2

323.0

1973

638

G40

ICD-10 Finland

Epilepsy

38.7

323.0

484

130

R53

ICD-10 Finland

Malaise and fatigue

4.0

323.0

2253

6677

N06AB04

ATC

citalopram; systemic

2.9

323.0

2578

10544

N03AX18

ATC

lacosamide; systemic

54.7

323.0

449

AA1BG

NOMESCO Finland

Standard MRI examination of brain with high intensity magnet

5.8

323.0

1526

2944

R51.80

ICD-10 Finland

Headache

7.7

323.0

1701

2538

N05AH04

ATC

quetiapine; oral

4.0

323.0

2776

8413

F10.25

ICD-10 Finland

Alcohol dependence continuous use

13.9

323.0

587

443

GD1AA

NOMESCO Finland

Thorax X-ray examination

2.4

323.0

4336

23676

R56.0

ICD-10 Finland

Febrile convulsions

6458.7

323.0

624

N03AX09

ATC

lamotrigine; oral

8.1

323.0

1175

1585

J18.9

ICD-10 Finland

Pneumonia, unspecified

2.7

323.0

2623

11215

G40.9

ICD-10 Finland

Epilepsy, unspecified

53.7

323.0

2553

611

GD1UA

NOMESCO Finland

Thorax X-ray examination outside radiological department

3.7

323.0

2037

6315

F10.1

ICD-10 Finland

Mental and behavioural disorders due to use of alcohol, Harmful use

9.0

323.0

2009

2652

F10.29

ICD-10 Finland

Addiction caused by alcohol UNS

13.2

323.0

816

658

N07BB01

ATC

disulfiram; oral

6.5

323.0

1051

1758

XF400

NOMESCO Finland

ECG with 12 standard connections

3.9

323.0

2309

7022

GD1QA

NOMESCO Finland

Supine thorax X-ray examination

5.1

323.0

2288

5334

W01

ICD-10 Finland

Fall on same level from slipping, tripping and stumbling

2.6

323.0

3488

16395

F10.31

ICD-10 Finland

Withdrawal symptoms caused by alcohol with seizures

73.1

323.0

639

E87.1

ICD-10 Finland

Hypo-osmolality and hyponatraemia

10.4

323.0

811

829

R56.8

ICD-10 Finland

Other and unspecified convulsions

4503599627370496.0

323.0

10542

183

Kela drug reimbursment

Lamotrigin and topiramate

40.7

323.0

612

158

N05BA04

ATC

oxazepam; oral

2.9

323.0

3001

12626

N05BA01

ATC

diazepam; systemic, rectal

6.1

323.0

2678

5446

N03AG01

ATC

valproic acid; systemic, rectal

15.3

323.0

2313

1873

G40.12

ICD-10 Finland

Simple partial seizures with secondary generalization

73.3

323.0

634

F32.9

ICD-10 Finland

Depressive episode, unspecified

3.5

323.0

1944

6244

P15

ICPC

Chronic alcohol abuse

9.1

323.0

739

856

N03AX14

ATC

levetiracetam; systemic

47.8

323.0

1799

445

N05AX08

ATC

risperidone; systemic

4.5

323.0

1306

3184

N06AX11

ATC

mirtazapine; oral

2.7

323.0

3719

17403

N05AH03

ATC

olanzapine; systemic

5.4

323.0

1244

2504

182

Kela drug reimbursment

Brivaracetam, eslikarbazepin, gabapentin, lacosamide, levetiracetam, perampanel, pregabalin, tiagabin and zonisamide

56.4

323.0

1548

317

T36

ICD-10 Finland

Poisoning by systemic antibiotics

8.9

323.0

1207

1486

R41.8

ICD-10 Finland

Other and unspecified symptoms and signs involving cognitive functions and awareness

4.7

322.0

1186

2717

F10.20

ICD-10 Finland

Alcohol dependence currently independent

11.9

321.9

615

541

N05CF01

ATC

zopiclone; oral

2.4

318.6

3398

16910

N03AE01

ATC

clonazepam; systemic

5.9

316.8

956

1745

G40.39

ICD-10 Finland

Other or unspecified generalized epileptic syndromes with atonic, clonic, myoclonic or tonic-clonic seizures

62.5

315.3

371

N88

ICPC

Epilepsy

56.0

313.9

376

S06.0

ICD-10 Finland

Concussion

3.6

308.7

1576

4861

N05AA02

ATC

levomepromazine; systemic

6.6

308.3

842

1348

Z00.4

ICD-10 Finland

General psychiatric examination, not elsewhere classified

3.6

302.4

1523

4641

112

Kela drug reimbursment

Severe psychotic and other severe mental disorders

4.1

302.4

1298

3444

WX700

NOMESCO Finland

Respiratory and circulatory monitoring

3.0

289.2

1968

7461

TPH04

NOMESCO Finland

Cathetrisation of vein

2.7

286.3

2353

10035

F10.00

ICD-10 Finland

Alcohol-related acute intoxication uncomplicated

10.8

274.8

550

529

WX892

NOMESCO Finland

Monitored bed care

4.3

272.7

1103

2755

XA800

NOMESCO Finland

Neuropsychological investigation

6.1

270.4

782

1345

F10.24

ICD-10 Finland

Alcohol depence active use

14.4

265.6

464

333

N03AB02

ATC

phenytoin; systemic

19.1

259.7

407

220

N05BA09

ATC

clobazam; oral

43.3

259.7

326

G41.9

ICD-10 Finland

Status epilepticus, unspecified

47.3

258.5

319

N05CD07

ATC

temazepam; oral

3.3

257.0

1476

4938

G40.19

ICD-10 Finland

Localization-related (focal)(partial) symptomatic epilepsy and epileptic syndromes with simple partial seizures

35.7

252.9

331

AA1BD

NOMESCO Finland

Extensive CT of head and brain

10.2

252.8

522

532

N06AX16

ATC

venlafaxine; oral

3.0

252.5

1689

6279

A49.9

ICD-10 Finland

Bacterial infection, unspecified

3.9

248.1

1132

3144

F10.09

ICD-10 Finland

Alcohol intoxication UNS

8.5

244.0

558

680

I69.3

ICD-10 Finland

Sequelae of cerebral infarction

4.5

240.9

927

2195

F10.26

ICD-10 Finland

Alcohol dependence periodic alcoholism

11.8

237.7

455

399

I63.9

ICD-10 Finland

Cerebral infarction, unspecified

3.6

237.7

1186

3546

F29

ICD-10 Finland

Unspecified nonorganic psychosis

5.2

236.5

788

1601

UJD10

NOMESCO Finland

Esophagoscopy, gastroscopy and duodenoscopy

2.3

232.5

2723

13799

N03AX16

ATC

pregabalin; oral

2.4

229.5

2232

10297

G40.10

ICD-10 Finland

Simple partial seizures

25.6

228.9

326

130

AA1CM

NOMESCO Finland

Extensive MRI examination of brain with 3 Tesla magnet

10.0

227.3

474

491

R41.0

ICD-10 Finland

Disorientation, unspecified

8.3

224.5

520

646

A28

ICPC

Limited function/disability NOS

3.0

223.7

1433

5145

G40.6

ICD-10 Finland

Grand mal seizures, unspecified (with or without petit mal)

52.7

222.4

269

F10.40

ICD-10 Finland

Withdrawal symptoms and delirium caused by alcohol without seizures

16.4

220.3

364

227

X59

ICD-10 Finland

Exposure to unspecified factor

2.4

219.7

2220

10415

N06AB10

ATC

escitalopram; oral

2.3

215.6

2319

11215

XA400

NOMESCO Finland

EEG

34.3

214.5

283

F10.30

ICD-10 Finland

Withdrawal symptoms caused by alcohol uncomplicated

14.3

211.2

369

264

AA1DG

NOMESCO Finland

Very extensive MRI examination of brain with high intensity magnet

7.2

210.5

537

773

F32.2

ICD-10 Finland

Severe depressive episode without psychotic symptoms

3.8

208.4

974

2745

A06AD11

ATC

lactulose; oral

2.8

208.0

1480

5671

WYA30

NOMESCO Finland

Preparations for expected poor cooperation

3.4

206.8

1095

3413

R10.4

ICD-10 Finland

Other and unspecified abdominal pain

2.0

200.6

3546

21176

W19

ICD-10 Finland

Unspecified fall

3.1

198.1

1229

4292

F10.39

ICD-10 Finland

Withdrawal symptoms caused by alcohol UNS

13.1

196.1

356

278

G40.89

ICD-10 Finland

Other epilepsy

46.4

195.5

242

G40.09

ICD-10 Finland

Other or unspecified partial (focal) idiopathic epilepsy or epileptic syndrome with local onset

49.5

191.4

234

N03AX11

ATC

topiramate; oral

8.3

188.8

437

541

JN3AE

NOMESCO Finland

Abdominal ultrasound examination

2.7

188.2

1418

5603

S06.5

ICD-10 Finland

Traumatic subdural haemorrhage

6.8

186.8

497

758

Z03.3

ICD-10 Finland

Observation for suspected nervous system disorder

4.2

186.6

770

1936

N05BA02

ATC

chlordiazepoxide; systemic

7.1

186.3

481

703

N05BA06

ATC

lorazepam; systemic, sublingual

4.5

186.2

703

1622

C03CA01

ATC

furosemide; systemic

2.2

186.0

2371

12297

TAB00

NOMESCO Finland

Lumbar puncture

5.1

184.6

624

1281

N03AX12

ATC

gabapentin; oral

2.7

184.2

1464

5969

F10.9

ICD-10 Finland

Mental and behavioural disorders due to use of alcohol, Unspecified mental and behavioural disorder

16.2

183.8

305

192

R4110

NOMESCO Finland

Physiotherapy

2.1

183.6

2629

14324

A02BC02

ATC

pantoprazole; systemic

1.8

182.8

5898

42955

R42

ICD-10 Finland

Dizziness and giddiness

2.3

182.7

1939

9224

C07AA05

ATC

propranolol; systemic

2.3

180.9

2057

10110

N07

ICPC

Convulsion/seizure

116.1

179.3

195

N02AX02

ATC

tramadol; systemic, rectal

1.9

177.2

3836

24399

S01.0

ICD-10 Finland

Open wound of scalp

3.3

176.8

986

3181

N05AF03

ATC

chlorprothixene; systemic

6.2

176.6

504

844

R11

ICD-10 Finland

Nausea and vomiting

3.4

176.1

936

2911

F10.21

ICD-10 Finland

Alcohol dependence currently abstinent, but staying in restrictive environment

14.2

176.0

308

221

F05.9

ICD-10 Finland

Delirium, unspecified

10.0

174.4

361

368

A09

ICD-10 Finland

Other gastroenteritis and colitis of infectious and unspecified origin

2.3

173.5

1839

8721

N06AB06

ATC

sertraline; oral

2.7

172.8

1330

5308

N05AX12

ATC

aripiprazole; systemic

4.3

171.1

678

1637

F32.10

ICD-10 Finland

Moderate depressive episode without somatic syndrome

2.9

169.0

1114

4030

F41.9

ICD-10 Finland

Anxiety disorder, unspecified

2.8

166.2

1222

4736

TKC20

NOMESCO Finland

Catheterisation of bladder

3.5

166.0

839

2505

N05AH02

ATC

clozapine; systemic

6.7

165.8

443

679

N05CD08

ATC

midazolam; nasal, systemic

7.3

165.0

417

590

N06AB03

ATC

fluoxetine; oral

2.6

163.5

1378

5780

N02AE01

ATC

buprenorphine; parenteral, sublingual, transdermal

3.0

163.4

1057

3775

R60.0

ICD-10 Finland

Localized oedema

3.5

162.4

830

2499

R40.2

ICD-10 Finland

Coma, unspecified

20.3

159.7

244

122

N05AD01

ATC

haloperidol; systemic

5.4

159.5

506

964

GD1PA

NOMESCO Finland

X-ray examination of the lungs in one projection

3.3

157.7

863

2736

N02BE01

ATC

paracetamol; systemic, rectal

1.8

156.2

8421

70212

F60.30

ICD-10 Finland

Emotionally unstable personality disorder, impulsive

7.6

154.7

380

515

F33.9

ICD-10 Finland

Recurrent depressive disorder, unspecified

4.4

154.0

591

1381

P16

ICPC

Acute alcohol abuse

7.5

153.3

379

519

X44

ICD-10 Finland

Accidental poisoning by and exposure to other and unspecified drugs, medicaments and biological substances

8.8

150.5

336

391

F10.41

ICD-10 Finland

Withdrawal symptoms and delirium caused by alcohol with seizures

51.1

149.9

182

N05BA12

ATC

alprazolam; oral

2.8

149.8

1084

4147

G40.2

ICD-10 Finland

Localization-related (focal)(partial) symptomatic epilepsy and epileptic syndromes with complex partial seizures

15.7

148.5

249

161

AAB10

NOMESCO Finland

Partial excision of intracranial lesion

13.5

148.5

265

199

J69.0

ICD-10 Finland

Pneumonitis due to food and vomit

7.9

147.0

349

449

WX730

NOMESCO Finland

Conventional respirator

8.5

146.6

334

402

F33.2

ICD-10 Finland

Recurrent depressive disorder, current episode severe without psychotic symptoms

4.0

146.4

628

1628

F10.49

ICD-10 Finland

Withdrawal symptoms and delirium caused by alcohol without information about seizures

19.8

144.9

223

114

N10

ICD-10 Finland

Acute tubulo-interstitial nephritis

2.6

143.0

1202

5013

AA1BM

NOMESCO Finland

MRI examination of brain with 3 Tesla magnet

11.5

142.6

275

244

L28

ICPC

Limited function/disability (L)

2.4

141.9

1341

5952

Z50.8

ICD-10 Finland

Care involving use of other rehabilitation procedures

3.2

141.1

811

2658

N05CF02

ATC

zolpidem; oral

2.2

140.8

1693

8434

N02AA05

ATC

oxycodone; systemic

2.5

140.5

1206

5082

C07AB07

ATC

bisoprolol; oral

1.7

137.8

3850

26024

N06AX21

ATC

duloxetine; oral

2.7

137.7

1007

3868

NA1AD

NOMESCO Finland

Cervical spine CT examination

4.3

136.5

537

1283

WX408

NOMESCO Finland

General anesthesy, balanced

1.9

134.6

2574

15369

N39.0

ICD-10 Finland

Urinary tract infection, site not specified

2.4

133.8

1272

5652

E87.6

ICD-10 Finland

Hypokalaemia

5.8

132.5

395

697

R4120

NOMESCO Finland

Occupational therapy

3.2

130.4

740

2400

G40.51

ICD-10 Finland

Epileptic seizures related to alcohol

118.3

130.0

141

G40.00

ICD-10 Finland

Benign childhood epilepsy with centrotemporal EEG spikes

50.7

128.4

156

N05AB03

ATC

perphenazine; systemic, rectal

4.3

125.9

499

1200

F19.1

ICD-10 Finland

Mental and behavioural disorders due to multiple drug use and use of other psychoactive substances, harmful use

12.5

125.2

231

187

B18.2

ICD-10 Finland

Chronic viral hepatitis C

8.9

125.1

277

318

Z72.1

ICD-10 Finland

Alcohol use

8.1

123.8

289

362

F20.9

ICD-10 Finland

Schizophrenia, unspecified

5.6

123.7

379

691

JN3AA

NOMESCO Finland

Abdominal X-ray examination without contrast

4.1

123.4

519

1319

G72.8

ICD-10 Finland

Other specified myopathies

9.1

123.0

269

302

Z01.8

ICD-10 Finland

Other specified special examinations

2.0

123.0

1971

10985

G40.21

ICD-10 Finland

Partial epileptic seizure with cloudiness and automatism

28.5

121.3

167

SPAT1254

SPAT

Administration of medicine

2.1

120.5

1601

8274

K92.0

ICD-10 Finland

Haematemesis

5.6

119.5

366

667

XF600

NOMESCO Finland

Bloodpressure measurement

3.2

118.6

687

2256

N05BE01

ATC

buspirone; oral

4.7

118.3

430

948

J15.9

ICD-10 Finland

Bacterial pneumonia, unspecified

2.7

117.5

871

3361

F60.31

ICD-10 Finland

Emotionally unstable personality disorder, borderline condition

7.5

116.5

285

384

A03FA01

ATC

metoclopramide; systemic, rectal

2.0

116.1

1667

8881

P18

ICPC

Medication abuse

16.9

114.9

187

112

F32.3

ICD-10 Finland

Severe depressive episode with psychotic symptoms

5.4

114.4

361

682

D64.9

ICD-10 Finland

Anaemia, unspecified

2.6

114.0

902

3613

G31.2

ICD-10 Finland

Degeneration of nervous system due to alcohol

16.4

113.8

187

115

EBA00

NOMESCO Finland

Extraction of tooth

1.7

113.8

3477

23775

N06AA09

ATC

amitriptyline; systemic

2.7

113.6

844

3259

A12AX

ATC

Calcium, combinations with vitamin D and/or other drugs

1.8

113.3

2383

14558

TPH07

NOMESCO Finland

Cathetrisation of artery

2.5

113.2

989

4185

F41.2

ICD-10 Finland

Mixed anxiety and depressive disorder

2.5

113.2

1011

4328

Z76.9

ICD-10 Finland

Person encountering health services in unspecified circumstances

2.8

112.4

803

3027

N06AX03

ATC

mianserin; oral

3.7

112.0

530

1490

P29

ICPC

Psychological sympt/compl other

2.8

111.2

767

2826

F20.00

ICD-10 Finland

Paranoid schizophrenia continuous

5.2

110.9

363

715

SPAT1265

SPAT

Breathalyser

8.4

110.7

252

303

K86.00

ICD-10 Finland

Acute pancreatitis caused by alcohol

7.7

110.4

266

350

A46

ICD-10 Finland

Erysipelas

2.2

108.1

1212

5795

M79.6

ICD-10 Finland

Pain in limb

1.7

107.3

3003

19953

F33.10

ICD-10 Finland

Recurrent depression, moderate episode without somatic syndrome

3.0

107.0

654

2226

E16.2

ICD-10 Finland

Hypoglycaemia, unspecified

8.3

106.9

246

301

G41.0

ICD-10 Finland

Grand mal status epilepticus

62.8

106.7

125

T90.5

ICD-10 Finland

Sequelae of intracranial injury

9.0

106.5

233

262

J01DB01

ATC

cefalexin; oral

1.6

105.4

8163

69975

F31.9

ICD-10 Finland

Bipolar affective disorder, unspecified

4.5

105.1

396

905

WX110

NOMESCO Finland

Local anesthesy

1.6

104.8

6936

57116

F60.9

ICD-10 Finland

Personality disorder, unspecified

7.4

104.6

259

355

F10.2

ICD-10 Finland

Mental and behavioural disorders due to use of alcohol, Dependence syndrome

8.6

104.5

235

277

N04AA02

ATC

biperiden; systemic

5.6

104.2

319

581

SPAT1240

SPAT

Therapeutic discussion

2.2

104.2

1243

6107

G40.4

ICD-10 Finland

Other generalized epilepsy and epileptic syndromes

37.5

104.0

134

R52.2

ICD-10 Finland

Other chronic pain

6.9

103.9

271

401

G45.9

ICD-10 Finland

Transient cerebral ischaemic attack, unspecified

2.9

103.5

688

2474

F11.22

ICD-10 Finland

Addiction-induced dependence is currently independent but uses substitute intermittent medication

17.3

103.0

166

PA2BD

NOMESCO Finland

Extensive CT angiography of brain

7.6

102.8

250

334

IAA01

NOMESCO Finland

Assessment of need for psychiatric treatment

4.5

102.7

382

862

WX882

NOMESCO Finland

High dependency care

4.5

101.9

383

873

P19

ICPC

Drug abuse

8.1

101.3

237

298

K70.3

ICD-10 Finland

Alcoholic cirrhosis of liver

7.9

101.0

240

309

L01AX03

ATC

temozolomide; systemic

15.1

100.9

171

114

R69

ICD-10 Finland

Unknown and unspecified causes of morbidity

19.2

100.6

156

F19.29

ICD-10 Finland

Addiction caused by several drugs in combination and by other psychoactive substances UNS

14.0

100.0

175

126

X58

ICD-10 Finland

Exposure to other specified factors

2.0

99.5

1457

7780

A02BC01

ATC

omeprazole; systemic

1.7

99.5

2320

14551

S18

ICPC

Laceration/cut

1.6

99.2

3684

26282

JN3BD

NOMESCO Finland

Extensive abdominal CT

2.4

98.7

942

4159

SPAT1222

SPAT

Counselling/guidance promoting independent living

2.1

98.5

1287

6562

J20.9

ICD-10 Finland

Acute bronchitis, unspecified

1.9

96.8

1519

8324

Z72.2

ICD-10 Finland

Drug use

13.0

96.7

175

136

EBA15

NOMESCO Finland

Extraction of large number of teeth

3.7

95.7

440

1206

R25.2

ICD-10 Finland

Cramp and spasm

5.1

95.3

314

623

A04

ICPC

Weakness/tiredness general

2.1

95.3

1261

6457

JN1AE

NOMESCO Finland

Ultrasound examination of upper part of abdomen

2.5

95.1

797

3284

N06AB05

ATC

paroxetine; oral

2.8

94.9

649

2375

F10.06

ICD-10 Finland

Alcohol-related acute intoxication with seizures

76.8

94.1

107

P99

ICPC

Psychological disorders other

4.1

93.5

390

982

F51.0

ICD-10 Finland

Nonorganic insomnia

2.0

93.1

1256

6480

R07.4

ICD-10 Finland

Chest pain, unspecified

1.8

93.0

2088

12907

Z03.9

ICD-10 Finland

Observation for suspected disease or condition, unspecified

1.9

92.7

1616

9187

SPAT1309

SPAT

Guidance related to psychoactive substances / risk behaviour

3.6

92.7

453

1306

FB1BD

NOMESCO Finland

Extensive CT examination of arteria pulmonalis

2.8

91.3

634

2339

F20.30

ICD-10 Finland

Undifferentiated schizophrenia continuous

5.9

91.3

267

460

R06.0

ICD-10 Finland

Dyspnoea

1.8

89.9

1931

11756

AAB00

NOMESCO Finland

Extirpation of intracranial lesion

7.5

89.2

219

297

SPAT1229

SPAT

Assessment of need for aid

2.7

89.1

639

2407

R52.9

ICD-10 Finland

Pain, unspecified

2.7

89.1

657

2516

N06AA12

ATC

doxepin; systemic

3.1

89.0

525

1742

N03AX23

ATC

brivaracetam; systemic

58.5

88.8

105

G40.30

ICD-10 Finland

Benign myoclonic eplilepsy in infancy

40.2

88.4

112

N05AN01

ATC

lithium; oral

4.4

88.3

336

775

AA1CD

NOMESCO Finland

Very extensive CT of head and brain

6.5

87.8

239

375

G40.11

ICD-10 Finland

Simple partial epileptic seizure that develops into a complex partial seizure

29.9

87.7

119

N17.9

ICD-10 Finland

Acute renal failure, unspecified

3.9

87.4

381

997

F13.29

ICD-10 Finland

Addiction caused by sedative and hypnotic UNS

21.4

87.1

130

V03AA01

ATC

5.4

86.3

270

505

S22.3

ICD-10 Finland

Fracture of rib

2.7

85.8

641

2471

J01MA12

ATC

levofloxacin; systemic

1.9

85.8

1469

8277

Z71.8

ICD-10 Finland

Other specified counselling

1.7

85.5

2224

14313

EB1HA

NOMESCO Finland

Panorama tomography of teeth and jaws or similar X-ray examination

1.5

84.8

3948

29418

7803A

ICD-9 Finland

General symptoms, Convulsions

6.6

84.3

225

344

N30.0

ICD-10 Finland

Acute cystitis

2.0

83.9

1126

5782

A41.9

ICD-10 Finland

Sepsis, unspecified

4.0

83.9

358

920

TPH15

NOMESCO Finland

Insertion of central venous catheter through external or internal jugular vein

2.8

83.8

565

2046

G44.2

ICD-10 Finland

Tension-type headache

2.1

83.6

1054

5272

Z01.0

ICD-10 Finland

Examination of eyes and vision

1.9

83.4

1460

8286

O99.3

ICD-10 Finland

Mental disorders and diseases of the nervous system complicating pregnancy, childbirth and the puerperium

5.7

81.9

245

434

ICZ03

NOMESCO Finland

Participation in compiling a psychiatric treatment plan

3.6

81.8

391

1106

K90

ICPC

Stroke/cerebrovascular accident

4.7

81.4

288

617

N05AB01

ATC

dixyrazine; systemic

6.8

81.3

212

314

SPAT1216

SPAT

Assessment of functional ability

2.0

81.2

1205

6435

Z53.2

ICD-10 Finland

Procedure not carried out because of patient's decision for other and unspecified reasons

6.4

80.8

220

346

F10.03

ICD-10 Finland

Alcohol-related acute intoxication with delirium

18.2

80.7

127

F61.0

ICD-10 Finland

Mixed personality disorders

5.4

80.6

253

475

SPAT1234

SPAT

Support of social functional capacity

3.1

80.6

482

1613

N03AX22

ATC

perampanel; oral

51.2

80.3

F11.25

ICD-10 Finland

Relationship caused by opiates continuously used

18.0

80.3

127

WX872

NOMESCO Finland

Intensive care

2.9

80.2

514

1801

IEY05

NOMESCO Finland

Dedicated profession-specific psychiatric intervention, individual

3.6

80.1

387

1105

G43.9

ICD-10 Finland

Migraine, unspecified

2.9

79.6

527

1884

F60.3

ICD-10 Finland

Emotionally unstable personality disorder

7.2

79.5

199

278

3039X

ICD-9 Finland

Alcohol dependence syndrome, Other and unspecified alcohol dependence

5.9

79.4

231

396

F13.22

ICD-10 Finland

Addiction relationship caused by sedatives and hypnotics currently independent but uses substitute intermittent medication

16.3

79.3

130

A10AB05

ATC

insulin aspart; parenteral (insulins and analog. for injection, fast-acting)

2.3

79.2

761

3358

79199

ICD-8 Finland

Headache

+∞

79.1

FM1AE

NOMESCO Finland

Standard cardiac ultrasound examination

1.9

79.0

1378

7797

J01FF01

ATC

clindamycin; systemic

1.6

79.0

2317

15366

F19.25

ICD-10 Finland

Addiction caused by several drugs in combination and by other psychoactive substances continuously used

24.1

78.6

113

P76

ICPC

Depressive disorder

2.5

78.4

680

2847

P01

ICPC

Feeling anxious/nervous/tense

1.9

78.3

1247

6831

E86

ICD-10 Finland

Volume depletion

5.3

78.3

248

471

F11.24

ICD-10 Finland

Addiction-induced dependence caused by opiates active addiction

26.7

78.1

109

D43.0

ICD-10 Finland

Neoplasm of uncertain or unknown behaviour: Brain, supratentorial

12.6

77.8

142

113

T81.4

ICD-10 Finland

Infection following a procedure, not elsewhere classified

2.2

77.7

892

4280

PA6BD

NOMESCO Finland

Extensive CT of neck arteries

3.5

77.6

385

1122

JN4BD

NOMESCO Finland

Extensive body CT

2.2

77.5

829

3853

F33.30

ICD-10 Finland

Recurrent depression, severe episode without somatic syndrome

7.1

77.4

197

282

NB1AA

NOMESCO Finland

Shoulder X-ray examination without contrast

2.6

77.3

587

2283

N06CA01

ATC

amitriptyline and psycholeptics; systemic

2.3

77.2

779

3520

K70.1

ICD-10 Finland

Alcoholic hepatitis

10.8

77.0

152

142

F02.89*G40.9

ICD-10 Finland

Dementia in epilepsy

60.1

76.5

WZC00

NOMESCO Finland

Planning of intervention or health care consultation

1.5

76.5

3033

21656

SPAT1301

SPAT

No procedures

1.6

76.1

2887

20396

A01

ICPC

Pain general/multiple sites

2.5

76.1

650

2699

F13.25

ICD-10 Finland

Addiction caused by sedative and hypnotic continuous use

17.3

76.0

122

WX404

NOMESCO Finland

Intravenous generell anesthesy

1.7

76.0

1753

10847

AAG50

NOMESCO Finland

Stereotactic intracranial radiotherapy

15.8

75.9

126

N06AA06

ATC

trimipramine; systemic

4.3

75.7

292

683

WZB00

NOMESCO Finland

Telephone receipt or other advice

1.6

75.6

2680

18620

F10.23

ICD-10 Finland

Alcohol dependence currently abstinent but using aversion-inducing or inhibitory medication

10.8

75.6

149

139

F41.09

ICD-10 Finland

UNS Panic Syndrome

3.5

75.4

373

1085

M54.5

ICD-10 Finland

Low back pain

1.6

75.2

2746

19212

SPAT1148

SPAT

Treatment of chronic ulcer or burn

2.0

75.2

1080

5683

I69.1

ICD-10 Finland

Sequelae of intracerebral haemorrhage

8.4

75.2

170

203

PH2AE

NOMESCO Finland

Ultrasound examination of lower leg veins

2.2

75.2

804

3735

SPAT1217

SPAT

Assessment of need for services (elderly/care support)

2.8

75.0

526

1950

A10AE04

ATC

insulin glargine; parenteral

2.1

74.9

889

4326

P72

ICPC

Schizophrenia

4.6

74.4

269

590

XF404

NOMESCO Finland

Ambulatory ECG

2.3

74.0

768

3513

S06.3

ICD-10 Finland

Focal brain injury

6.2

74.0

208

341

R1230

NOMESCO Finland

Neuropsychological evaluation of need and possibilities to rehabilitation

7.3

73.9

183

252

R33

ICD-10 Finland

Retention of urine

2.4

73.8

674

2896

F19.24

ICD-10 Finland

Addiction relationship caused by several drugs in combination and by other psychoactive substances active addiction

21.9

73.7

109

AA1DM

NOMESCO Finland

Very extensive MRI examination of brain with 3 Tesla magnet

8.7

73.6

163

188

K59.09

ICD-10 Finland

Constipation, unspecified

2.8

73.5

500

1818

E10.00

ICD-10 Finland

Insulin-dependent diabetes diabetic hypoglycemic coma

6.1

73.4

208

345

ZX120

NOMESCO Finland

Intravenous

2.3

72.8

762

3500

WX002

NOMESCO Finland

Sedation and analgesia

1.7

72.7

1580

9586

F32.11

ICD-10 Finland

Moderate depressive episode with somatic syndrome

3.8

72.5

324

867

T74.1

ICD-10 Finland

Physical abuse

4.3

72.5

283

670

F44.5

ICD-10 Finland

Dissociative convulsions

708.9

72.0

R10.1

ICD-10 Finland

Pain localized to upper abdomen

1.8

70.8

1277

7289

AA5BD

NOMESCO Finland

CT of cerebral ischaemia

5.0

70.3

237

483

F43.22

ICD-10 Finland

Adaptation disorder with mixed anxiety and depression

3.0

70.2

425

1433

R56

ICD-10 Finland

Convulsions, not elsewhere classified

688.7

70.0

SPAT1230

SPAT

Aid fitting and borrowing and monitoring of use

1.8

69.9

1259

7183

NA3AA

NOMESCO Finland

Lumbar spine X-ray examination without contrast

2.2

69.9

730

3349

W10

ICD-10 Finland

Fall on and from stairs and steps

2.7

69.6

499

1874

B01AB05

ATC

enoxaparin; parenteral

1.6

69.4

2260

15319

G43.0

ICD-10 Finland

Migraine without aura [common migraine]

2.7

69.3

512

1957

F25.9

ICD-10 Finland

Schizoaffective disorder, unspecified

6.1

69.2

196

325

I61.9

ICD-10 Finland

Intracerebral haemorrhage, unspecified

6.3

69.1

191

307

Z03.2

ICD-10 Finland

Observation for suspected mental and behavioural disorders

4.7

68.8

245

529

P74

ICPC

Anxiety disorder/anxiety state

2.8

68.7

481

1781

S06.2

ICD-10 Finland

Diffuse brain injury

6.5

68.3

185

289

G81.9

ICD-10 Finland

Hemiplegia, unspecified

8.6

68.3

152

177

F19.20

ICD-10 Finland

Addiction relationship caused by several drugs in combination and by other psychoactive substances currently independent

12.3

68.2

126

103

S42.2

ICD-10 Finland

Fracture of upper end of humerus

2.9

68.0

431

1497

SPAT1227

SPAT

Substance abuse rehabilitation

8.4

67.9

154

185

A29

ICPC

General symptom/complaint other

2.0

67.9

949

4932

P01AB01

ATC

metronidazole; oral, rectal

1.5

67.6

3160

23266

D50.9

ICD-10 Finland

Iron deficiency anaemia, unspecified

2.4

67.3

609

2604

ICB01

NOMESCO Finland

Psychiatric treatment plan, standard

3.4

66.8

337

996

K08.3

ICD-10 Finland

Retained dental root

2.3

66.5

630

2756

XX1XW

NOMESCO Finland

Extensive written report from radiologist

4.6

66.4

238

518

B01AC30

ATC

platelet aggregation inhibitors excl. heparin - combinations

2.6

66.2

514

2020

A10AC01

ATC

insulin (human); parenteral (insulins and analog. for injection, intermediate-acting)

2.2

66.2

729

3425

RS220

NOMESCO Finland

6.2

66.2

184

298

N02AA59

ATC

codeine, combinations excl. psycholeptics; systemic

1.4

66.1

3831

29449

I63.3

ICD-10 Finland

Cerebral infarction due to thrombosis of cerebral arteries

3.2

65.9

364

1151

IAZ97

NOMESCO Finland

Psychiatric consultation in another specialty

5.8

65.6

192

332

N05AA01

ATC

chlorpromazine; systemic, rectal

5.4

65.6

205

384

N06AX12

ATC

bupropion; oral

2.3

65.3

629

2773

K04.5

ICD-10 Finland

Chronic apical periodontitis

1.6

65.0

2083

14030

G40.52

ICD-10 Finland

Epileptic seizures related to drugs

116.7

64.7

Y83

ICD-10 Finland

Surgical operation and other surgical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

2.4

64.7

606

2636

R52.1

ICD-10 Finland

Chronic intractable pain

44.5

64.7

F33.11

ICD-10 Finland

Recurrent depression, moderate episode of somatic syndrome

4.3

64.7

249

582

Z76.8

ICD-10 Finland

Persons encountering health services in other specified circumstances

3.1

64.6

378

1245

R60.9

ICD-10 Finland

Oedema, unspecified

3.6

64.6

305

855

XPX99

NOMESCO Finland

Other diagnostic examination of periferal vessel

2.5

64.5

527

2132

J01MA02

ATC

ciprofloxacin; systemic

1.5

64.3

3120

23097

N05AD03

ATC

melperone; systemic

5.9

64.1

187

322

L17

ICPC

Foot/toe symptom/complaint

1.6

64.1

2092

14150

G40.1

ICD-10 Finland

Localization-related (focal)(partial) symptomatic epilepsy and epileptic syndromes with simple partial seizures

16.0

63.7

105

RS222

NOMESCO Finland

6.6

63.4

169

259

N06AX05

ATC

trazodone; oral

3.9

63.3

273

708

R25.1

ICD-10 Finland

Tremor, unspecified

3.8

63.3

280

743

PA6DE

NOMESCO Finland

Neck artery ultrasound examination with Doppler method

2.9

63.1

414

1472

ZXA00

NOMESCO Finland

Right side

1.6

63.1

2114

14385

N03AX15

ATC

zonisamide; oral

18.0

62.9

R51

ICD-10 Finland

Headache

2.9

62.6

409

1448

R10.3

ICD-10 Finland

Pain localized to other parts of lower abdomen

1.6

62.3

1747

11354

P03

ICPC

Feeling depressed

1.9

62.2

976

5293

PA7AD

NOMESCO Finland

CT angiography of head and neck vasculature

4.3

62.1

243

577

K86.08

ICD-10 Finland

Alcohol-induced chronic pancreatitis

12.5

61.7

113

H02AB09

ATC

hydrocortisone; systemic

4.4

61.5

235

545

E10.9

ICD-10 Finland

Type 1 diabetes mellitus, Without complications

2.5

61.5

533

2225

F44.9

ICD-10 Finland

Dissociative [conversion] disorder, unspecified

11.1

61.4

119

108

A86

ICD-10 Finland

Unspecified viral encephalitis

14.2

61.3

106

S00.0

ICD-10 Finland

Superficial injury of scalp

4.2

60.8

242

584

J45.9

ICD-10 Finland

Asthma, unspecified

1.7

60.7

1406

8655

UJF32

NOMESCO Finland

Coloscopy

1.6

60.6

1860

12368

J01CR02

ATC

amoxicillin and beta-lactamase inhibitor; systemic

1.4

60.5

4775

38693

B01AA03

ATC

warfarin; systemic

1.7

60.4

1440

8940

N05AF05

ATC

zuclopenthixol; systemic

6.7

60.3

159

240

N18

ICPC

Paralysis/weakness

4.9

60.2

206

427

QDB10

NOMESCO Finland

Major dressing of wound of skin of lower limb

2.7

60.2

428

1600

IGY02

NOMESCO Finland

Psychiatric monitoring contact

3.6

59.8

287

815

SPAT1247

SPAT

Outpatient detoxication and monitoring

9.2

59.5

127

138

F15.2

ICD-10 Finland

Mental and behavioural disorders due to use of other stimulants, including caffeine, dependence syndrome

11.7

59.4

112

A02BC05

ATC

esomeprazole; systemic

1.5

59.3

3096

23182

C71.10

ICD-10 Finland

Malignant tumor in frontal lobe without histology

19.4

59.3

7840A

ICD-9 Finland

Symptoms involving head and neck, Headache

+∞

59.3

R02

ICPC

Shortness of breath/dyspnoea

1.9

59.2

959

5255

I10

ICD-10 Finland

Essential (primary) hypertension

1.4

59.0

4286

34163

F31.30

ICD-10 Finland

Bipolar disorder Depressive episode without somatic syndrome

4.1

58.9

243

606

H53.4

ICD-10 Finland

Visual field defects

4.3

58.7

225

524

C08CA01

ATC

amlodipine; oral

1.5

58.7

2563

18486

H02AB02

ATC

dexamethasone; systemic

2.1

58.6

721

3548

K92.1

ICD-10 Finland

Melaena

2.6

58.6

445

1728

Z04.8

ICD-10 Finland

Examination and observation for other specified reasons

1.9

58.4

995

5548

J01DA01

ATC

[U] cefalexin; systemic

1.4

58.1

5671

47555

H02AB06

ATC

prednisolone; systemic

1.4

58.0

3748

29212

R2130

NOMESCO Finland

Counselling and guidance which enhance independent living

2.1

57.7

702

3441

M54.9

ICD-10 Finland

Dorsalgia, unspecified

1.9

57.7

876

4690

AA1AG

NOMESCO Finland

Short MRI examination of brain with median intensity magnet

5.5

57.7

177

325

SPAT1137

SPAT

Taking care of patient’s/customer’s hygiene

2.8

57.6

385

1384

F43.1

ICD-10 Finland

Post-traumatic stress disorder

3.5

57.4

284

827

F13.1

ICD-10 Finland

Mental and behavioural disorders due to use of sedatives or hypnotics, harmful use

11.9

57.3

107

SAA01

NOMESCO Finland

Simple examination of mouth

1.4

57.3

6812

59022

F03

ICD-10 Finland

Unspecified dementia

3.2

57.2

323

1038

F13.24

ICD-10 Finland

Addiction relationship caused by sedative and hypnotic active addiction

18.2

56.8

A41.5

ICD-10 Finland

Sepsis due to other Gram-negative organisms

3.7

56.7

263

727

ZXA05

NOMESCO Finland

Left side

1.6

56.6

1962

13416

K02.1

ICD-10 Finland

Caries of dentine

1.4

56.4

5546

46459

JN3AD

NOMESCO Finland

Abdominal CT examination

2.2

56.3

604

2798

N29

ICPC

Neurological sympt/complt other

4.4

56.1

212

487

R62.0

ICD-10 Finland

Delayed milestone

64.9

56.1

N02AJ06

ATC

codeine and paracetamol; systemic

1.4

56.0

3097

23396

WYA05

NOMESCO Finland

Emergency visit or other similar visit involving procedures

1.4

56.0

4417

35618

I95.1

ICD-10 Finland

Orthostatic hypotension

3.9

55.8

240

622

X57

ICD-10 Finland

Unspecified privation

3.7

55.7

257

707

M03BX01

ATC

baclofen; systemic

4.8

55.6

191

398

F11.29

ICD-10 Finland

Addiction caused by opiates UNS

19.3

55.4

RS221

NOMESCO Finland

4.9

55.1

188

389

F05.8

ICD-10 Finland

Other delirium

11.2

55.1

106

R63.4

ICD-10 Finland

Abnormal weight loss

4.0

55.0

230

581

A02BC03

ATC

lansoprazole; oral

1.5

55.0

2153

15123

F34.1

ICD-10 Finland

Dysthymia

2.9

55.0

361

1283

A10AB01

ATC

insulin (human); parenteral (insulins and analog. for injection, fast-acting)

2.6

54.9

410

1576

N01

ICPC

Headache

1.8

54.8

1111

6555

IGY01

NOMESCO Finland

Accelerated psychiatric treatment contact

3.7

54.7

253

698

F13.20

ICD-10 Finland

Addiction relationship caused by sedatives and hypnotics currently independent

14.3

54.6

A41.0

ICD-10 Finland

Sepsis due to Staphylococcus aureus

4.7

54.6

194

419

EB1AA

NOMESCO Finland

Tooth X-ray examination

1.4

54.4

4960

40922

ZXC95

NOMESCO Finland

Use of surgical navigator

6.0

54.3

154

257

F41.1

ICD-10 Finland

Generalized anxiety disorder

2.4

54.2

506

2192

S32.0

ICD-10 Finland

Fracture of lumbar vertebra

3.4

54.0

278

835

SPAT1307

SPAT

Psychosocial counselling and guidance

2.0

54.0

765

3985

I50.9

ICD-10 Finland

Heart failure, unspecified

1.9

53.7

884

4867

Z72.8

ICD-10 Finland

LabWAS

↥

(ID) Name

N Cases

N Controls

-log₁₀(p)

cases

controls

cases

controls

unit

-log₁₀(p)

N cases

N controls

(42870588) Differential panel, method unspecified - Blood

4756

28015

2.10

319.71

7.1

5.4

—

(3014218) Bicarbonate [Moles/volume] standard in Arterial blood

1178

3605

3.46

308.34

9.2

10.1

24.0

24.1

mmol/l

0.45

1115

3373

(3033658) Prothrombin time (PT) actual/Normal

3961

20216

2.37

307.65

5.9

3.4

88.3

90.3

5.30

3869

19730

(3023368) Bacteria identified in Blood by Culture

4193

18480

2.87

307.65

5.5

3.4

—

(3027946) Carbon dioxide [Partial pressure] in Arterial blood

2201

7759

3.19

307.65

8.2

7.5

5.1

kpa

0.25

2107

7393

(3018677) aPTT in Platelet poor plasma by Coagulation assay

3035

10850

3.33

307.65

2.6

2.1

29.4

29.9

3.71

2949

10520

(3048469) 10-Hydroxycarbazepine [Moles/volume] in Serum or Plasma

769

182

44.41

307.65

2.6

2.4

53.7

53.4

umol/l

0.05

685

153

(3024561) Albumin [Mass/volume] in Serum or Plasma

5681

32660

2.32

307.65

5.9

4.4

34.7

36.3

g/l

64.45

5291

30197

(3007628) Bicarbonate [Moles/volume] standard in Venous blood

1304

3582

3.90

307.65

5.5

3.9

23.8

23.9

mmol/l

0.70

1201

3251

(4198724)

442

477

9.45

307.65

3.4

1.8

—

(3005895) Myoglobin [Mass/volume] in Serum or Plasma

1330

2066

7.00

307.65

2.5

2.4

366.0

729.9

ug/l

2.32

1266

1918

(3016431) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Serum or Plasma

7239

37049

3.23

307.65

8.9

5.8

1.2

mmol/l

52.97

6287

31135

(3027801) Oxygen [Partial pressure] in Arterial blood

2201

7757

3.19

307.65

8.2

7.5

12.9

12.8

kpa

0.66

2103

7387

(3021347) Calcium.ionized [Moles/volume] in Serum or Plasma

6785

33522

3.21

307.65

8.1

5.3

1.2

mmol/l

53.12

6442

30150

(3018418) pH of Serum or Plasma

4635

21052

2.88

307.65

4.6

3.5

7.4

0.08

929

3886

(3016293) Bicarbonate [Moles/volume] in Serum or Plasma

1706

4669

4.02

307.65

8.0

7.7

24.4

24.7

mmol/l

1.49

1695

4636

(3024354) Oxygen [Partial pressure] in Venous blood

1745

5361

3.58

307.65

4.7

3.0

4.8

4.7

kpa

0.85

1671

5175

(3032080) INR in Blood by Coagulation assay

5500

30136

2.44

307.65

8.5

7.6

1.2

inr

7.08

1703

8721

(3002173) Hemoglobin [Mass/volume] in Arterial blood

1741

6505

2.91

307.65

9.0

8.3

122.1

123.3

g/l

1.41

1697

6240

(3020044) Glucose [Moles/volume] in Cerebral spinal fluid

796

1273

6.53

307.65

1.6

1.3

3.9

3.7

mmol/l

1.98

738

1200

(3044290) Cell count panel - Cerebral spinal fluid

730

1211

6.26

307.65

1.8

1.4

—

(3014576) Chloride [Moles/volume] in Serum or Plasma

2187

8712

2.80

307.65

8.7

6.9

103.6

104.8

mmol/l

18.27

2127

8527

(3012544) pH of Venous blood

2090

6686

3.51

307.65

5.2

3.6

7.4

0.36

(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection

2685

10534

2.94

307.65

2.1

1.6

—

(3020191) Ethanol [Moles/volume] in Serum or Plasma

595

644

9.53

307.65

2.1

1.2

1.5

promille

2.51

465

505

(3003458) Phosphate [Moles/volume] in Serum or Plasma

2407

9373

2.91

307.65

6.8

5.4

1.1

mmol/l

0.02

2266

8710

(3003396) Base excess in Arterial blood by calculation

2219

7767

3.22

307.65

8.1

7.5

0.9

0.8

mmol/l

0.34

1738

6005

(3006140) Bilirubin.total [Moles/volume] in Serum or Plasma

6674

40223

2.38

307.65

7.6

5.0

11.7

12.0

umol/l

0.79

6299

37783

(3019473) Protein [Mass/volume] in Cerebral spinal fluid

860

1468

6.14

307.65

1.7

1.3

501.7

504.1

mg/l

0.03

823

1399

(3007220) Creatine kinase [Enzymatic activity/volume] in Serum or Plasma

6125

20840

4.76

307.65

3.4

1.9

283.3

234.9

u/l

1.50

5924

19454

(3027475) Erythrocytes [#/volume] in Cerebral spinal fluid

760

1307

6.05

307.65

1.8

1.4

743.6

4068.3

e6/l

0.60

621

1034

(3018980) carBAMazepine [Moles/volume] in Serum or Plasma

363

169

21.82

307.65

3.0

2.9

29.3

28.0

umol/l

0.65

254

133

(3021447) Carbon dioxide [Partial pressure] in Venous blood

2067

6449

3.60

307.65

5.2

3.6

5.9

5.8

kpa

1.47

1985

6254

(3012095) Magnesium [Moles/volume] in Serum or Plasma

3126

10984

3.42

307.65

4.4

3.1

0.8

mmol/l

26.83

2953

10234

(3000991) Gas panel - Venous blood

1907

6084

3.48

307.65

8.9

8.3

—

(3013826) Glucose [Moles/volume] in Serum or Plasma

8011

47921

2.84

307.65

7.3

4.0

6.6

6.7

mmol/l

0.50

7636

43770

(3016502) Oxygen saturation in Arterial blood

1875

6992

2.94

307.65

8.9

7.9

95.5

95.8

1.17

1817

6716

(3002032) Base excess in Venous blood by calculation

2054

6421

3.59

307.65

5.2

3.6

1.6

1.7

mmol/l

0.53

1690

5072

(3016914) Bacteria identified in Cerebral spinal fluid by Culture

475

448

10.85

307.65

1.6

—

(3003031) Transferrin.carbohydrate deficient.disialo/Transferrin.total in Serum or Plasma

2760

12753

2.46

307.65

2.9

1.7

1.8

1.4

72.37

2416

11393

(3028707) Methadone [Presence] in Urine by Screen method

966

2066

4.92

307.65

5.2

2.5

—

(3013721) Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma

4802

27744

2.16

307.65

4.2

2.9

36.5

32.8

u/l

3.10

4534

26268

(3016771) Amylase [Enzymatic activity/volume] in Serum or Plasma

4291

23833

2.19

307.65

3.4

2.2

56.1

59.3

u/l

3.02

3990

21882

(3009466) Valproate [Moles/volume] in Serum or Plasma

1331

915

15.97

307.65

4.9

5.1

369.7

373.8

umol/l

0.28

1193

771

(3023183) Ammonium ion [Moles/volume] in Plasma

1017

1190

9.10

307.65

3.1

2.5

34.4

33.5

umol/l

0.48

891

1026

(3003181) Sodium [Moles/volume] in Urine

579

897

6.64

307.65

1.6

1.5

67.3

67.1

mmol/l

0.03

454

713

(3019800) Troponin T.cardiac [Mass/volume] in Serum or Plasma

4868

27770

2.20

307.65

4.5

2.8

68.2

82.9

ng/l

0.16

3460

17069

(3038288) Influenza virus B RNA [Presence] in Specimen by NAA with probe detection

1967

7062

3.08

307.65

2.1

1.5

—

(3043924) Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection

1956

7008

3.08

307.65

2.0

1.5

—

(3026782) Osmolality of Urine

3065

14698

2.41

307.65

3.1

2.4

528.7

571.9

mosm/kgh2o

18.18

2675

12339

(3014111) Lactate [Moles/volume] in Serum or Plasma

1945

5965

3.63

307.65

7.6

7.5

1.5

1.4

mmol/l

4.30

1826

5734

(3016543) Leukocytes [#/volume] in Cerebral spinal fluid

760

1308

6.05

307.65

1.7

1.4

32.2

17.5

e6/l

0.40

582

975

(3021337) Troponin I.cardiac [Mass/volume] in Serum or Plasma

2802

13546

2.35

306.66

4.4

3.1

279.2

715.7

ng/l

4.75

2090

10014

(3020779) Urea [Moles/volume] in Serum or Plasma

1676

6330

2.87

306.27

7.9

6.6

8.0

9.3

mmol/l

10.71

1592

6026

(3016894) Varicella zoster virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

313

268

11.80

303.34

1.2

1.1

—

(3008733) Herpes simplex virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

306

255

12.12

301.73

1.2

1.1

—

(3019779) Phenytoin [Moles/volume] in Serum or Plasma

183

39.85

298.11

2.7

4.7

42.3

37.1

umol/l

0.89

165

(3036481) Cortisol [Moles/volume] in Serum or Plasma

1667

6395

2.82

295.23

2.3

2.2

383.0

381.4

nmol/l

0.08

1528

5854

(3013650) Neutrophils [#/volume] in Blood by Automated count

7104

49363

1.99

290.95

13.0

7.5

4.2

4.1

e9/l

6.82

6167

42578

(3006315) Basophils [#/volume] in Blood

6347

42585

1.97

286.11

7.6

5.3

0.0

e9/l

1.25

5448

36560

(3001604) Monocytes [#/volume] in Blood

6316

42403

1.96

283.13

7.6

5.3

0.6

e9/l

8.96

5424

36414

(3019309) Folate [Moles/volume] in Red Blood Cells

2635

12811

2.31

281.87

1.9

1.7

1180.8

1147.4

nmol/l

1.00

2044

9580

(3013115) Eosinophils [#/volume] in Blood

6503

44195

1.95

280.02

8.4

5.5

0.2

e9/l

7.68

5644

38599

(3035995) Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma

8626

64723

2.04

276.58

9.4

6.0

82.1

77.1

u/l

15.21

8189

60470

(3026008) Bacteria identified in Urine by Culture

3821

21666

2.07

275.95

3.5

2.5

—

(3002582) Erythrocytes [#/volume] in Urine

4089

23791

2.04

274.94

4.0

2.8

83.9

93.9

e6/l

0.15

3258

17684

(3019198) Lymphocytes [#/volume] in Blood

6485

44216

1.94

274.51

7.6

5.3

1.9

2.0

e9/l

0.99

5643

38782

(3022096) Basophils/100 leukocytes in Blood

5845

38597

1.94

271.24

7.8

5.5

0.6

0.7

10.33

5485

35840

(3006504) Eosinophils/100 leukocytes in Blood

5984

40005

1.92

265.72

7.8

5.4

2.6

2.9

16.73

5611

37123

(3019069) Monocytes/100 leukocytes in Blood

6010

40258

1.92

265.06

8.1

5.7

8.8

8.5

12.16

5646

37581

(3030467) Casts [#/volume] in Urine by Automated count

3781

21720

2.03

260.71

3.8

2.7

0.4

e6/l

0.03

2976

15788

(586526) SARS-CoV-2 (COVID-19) RNA [Presence] in Nasopharynx by NAA with probe detection

1130

3759

3.17

256.72

1.6

1.4

—

(3023410) Appearance of Cerebral spinal fluid

402

595

6.86

253.82

2.1

1.6

—

(3006217) Methemoglobin/Hemoglobin.total in Arterial blood

1232

4343

3.00

253.00

10.0

9.6

0.7

0.84

1224

4323

(3035999) Lactate [Moles/volume] in Cerebral spinal fluid

337

415

8.21

250.14

1.4

1.3

2.1

1.9

mmol/l

1.14

306

393

(1001509) Gas and Carbon monoxide and Electrolytes panel - Arterial blood

332

403

8.33

249.36

1.7

1.6

—

(3028653) Carboxyhemoglobin/Hemoglobin.total in Arterial blood

1225

4351

2.98

248.02

10.0

9.5

1.5

1.3

6.78

1217

4330

(3002030) Lymphocytes/100 leukocytes in Blood

6136

41990

1.88

247.24

7.8

5.4

27.6

29.2

23.48

5760

39027

(3013742) Prealbumin [Mass/volume] in Serum or Plasma

1622

6691

2.60

246.44

2.7

2.3

0.2

g/l

5.09

1455

6245

(36304419) Bacteria [Presence] in Urine

3684

21389

2.00

243.43

3.8

2.7

—

(3015399) Transferrin receptor.soluble [Mass/volume] in Serum or Plasma

3441

19528

2.02

242.33

2.4

2.1

2.9

2.8

mg/l

1.83

2913

16631

(3033386) Bacteria [Presence] in Cerebral spinal fluid by Light microscopy

272

271

10.11

237.64

1.7

1.6

—

(3018010) Neutrophils/100 leukocytes in Blood

6027

41371

1.85

236.91

7.6

5.3

57.2

56.3

5.75

5667

38642

(3023024) Carbon dioxide [Partial pressure] in Capillary blood

1294

4858

2.82

236.15

5.3

3.6

5.2

5.1

kpa

2.17

1219

4509

(3012501) Base excess in Blood by calculation

618

1445

4.39

235.84

4.6

3.6

2.3

mmol/l

0.15

422

924

(3027315) Oxygen [Partial pressure] in Blood

619

1450

4.38

235.66

4.6

3.6

8.6

8.9

kpa

3.23

609

1418

(3013290) Carbon dioxide [Partial pressure] in Blood

618

1446

4.39

235.63

4.6

3.6

5.1

5.0

kpa

1.90

608

1415

(3011288) Drugs identified in Urine by Screen method

1090

3731

3.07

235.14

7.1

2.5

—

(3016018) Differential panel - Cerebral spinal fluid

406

657

6.27

235.11

1.8

1.5

—

(3000850) Epithelial cells [#/volume] in Urine

2949

16003

2.08

233.64

3.1

2.3

6.3

5.3

e6/l

3.14

2639

13824

(3009343) pH of Capillary blood

1279

4805

2.82

232.98

5.4

3.6

7.4

0.62

173

503

(3010421) pH of Blood

671

1687

4.09

232.58

4.6

3.6

7.4

4.83

608

1414

(1001926) Buprenorphine [Presence] in Urine by Screen method

1204

4383

2.90

232.56

4.7

1.9

—

(3015377) Calcium [Moles/volume] in Serum or Plasma

4079

24903

1.92

229.86

3.8

2.9

2.3

2.4

mmol/l

14.91

3591

21725

(3018095) Leukocytes [#/volume] in Urine

4546

28794

1.88

228.39

4.6

3.1

73.1

77.6

e6/l

0.17

3417

19294

(43055554) Base excess.100% oxygenated [Moles/volume] standard in Capillary blood by calculation

1246

4665

2.82

228.26

5.4

3.5

1.5

1.4

mmol/l

0.10

903

3327

(40758558) Short blood count panel - Blood

3536

20621

1.97

228.00

9.3

5.7

—

(3016417) Amylase.pancreatic [Enzymatic activity/volume] in Serum or Plasma

1622

6943

2.50

226.99

3.3

2.2

32.9

49.8

u/l

1.58

1391

5919

(3031040) Bacteria [#/volume] in Urine by Automated count

7605

56537

1.85

226.66

5.5

3.5

1876.8

1610.1

e6/l

0.13

113

799

(3028271) Lactate [Moles/volume] in Capillary blood

484

968

5.10

223.32

2.5

1.6

2.2

1.7

mmol/l

5.73

471

943

(3004119) Hemoglobin [Mass/volume] in Venous blood

1106

4021

2.88

213.50

4.5

3.2

129.6

132.0

g/l

2.64

1079

3926

(43054903) Holo-transcobalamin II [Moles/volume] in Serum

4767

31526

1.80

201.74

2.1

1.8

93.0

96.0

pmol/l

4.37

2679

16677

(3000081) cloZAPine [Moles/volume] in Serum or Plasma

367

629

5.91

200.34

22.6

19.2

5850.5

1360.2

nmol/l

0.80

362

608

(36031861) Influenza virus A and B and SARS-CoV-2 (COVID-19) and Respiratory syncytial virus RNA panel - Respiratory system specimen by NAA with probe detection

1022

3687

2.89

199.69

1.8

1.5

—

(3024889) Methemoglobin/Hemoglobin.total in Venous blood

879

2914

3.13

199.47

4.2

2.8

0.7

0.79

861

2783

(3016879) Cocaine [Presence] in Urine

1313

5392

2.57

199.19

4.8

1.8

—

(3021960) Folate [Moles/volume] in Serum or Plasma

2938

16798

1.95

196.04

1.7

1.5

18.6

20.2

nmol/l

7.88

2613

14412

(3008832) Norclozapine [Moles/volume] in Serum or Plasma

357

610

5.92

195.47

15.3

13.4

2246.8

824.7

nmol/l

0.47

351

591

(3044640) Blood type and Crossmatch panel - Blood

4067

25873

1.82

194.06

2.9

2.0

—

(3000764) Benzodiazepines [Presence] in Urine

1363

5799

2.48

191.51

4.7

1.8

—

(3019060) Gas panel - Arterial blood

1117

4331

2.70

189.97

6.2

4.7

—

(3028300) Cannabinoids [Presence] in Urine

1368

5872

2.46

188.42

4.8

1.8

—

(3051552) Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection

1147

4530

2.65

187.99

1.9

1.5

—

(1616796) Gas panel - Central venous blood

553

1415

3.99

186.62

4.0

3.5

—

(3027008) Opiates [Presence] in Urine

1361

5863

2.45

185.87

4.4

1.8

—

(3022806) Fractional oxyhemoglobin in Capillary blood

396

780

5.15

185.73

2.4

1.6

89.5

90.0

0.77

383

767

(3020485) Acetaminophen [Moles/volume] in Serum or Plasma

244

295

8.31

183.72

3.2

1.9

150.7

181.4

umol/l

0.44

124

147

(3014973) Borrelia burgdorferi IgM Ab [Units/volume] in Cerebral spinal fluid

373

706

5.35

182.97

1.1

—

16.4

—

(3028626) Oxygen [Partial pressure] in Capillary blood

677

2022

3.44

181.88

6.2

3.9

8.9

8.8

kpa

0.94

640

1901

(3005772) Bilirubin.conjugated [Moles/volume] in Serum or Plasma

1756

8536

2.20

180.57

3.2

2.5

9.3

8.3

umol/l

0.78

1467

7411

(3043362) Influenza virus B Ag [Presence] in Nasopharynx by Immunoassay

506

1259

4.09

177.36

1.5

1.2

—

(3046524) Influenza virus A Ag [Presence] in Nasopharynx by Immunoassay

506

1260

4.09

177.16

1.5

1.2

—

(3022217) INR in Platelet poor plasma by Coagulation assay

1782

8777

2.17

177.04

19.4

23.4

1.3

inr

0.25

229

1204

(3022948) Iron [Moles/volume] in Serum or Plasma

2179

11587

2.04

176.72

2.8

2.3

12.3

13.8

umol/l

16.26

1986

10783

(40767503) Oxygen content in Capillary blood by calculation

528

1367

3.94

175.19

3.0

2.3

16.7

16.9

0.26

231

723

(3004789) Transferrin [Mass/volume] in Serum or Plasma

2024

10544

2.07

173.32

2.8

2.3

2.4

g/l

11.73

1839

9772

(3008152) Bicarbonate [Moles/volume] in Arterial blood

1066

4223

2.63

173.14

9.1

6.7

24.5

24.4

mmol/l

0.22

1010

3907

(3021589) Normoblasts [#/volume] in Blood

5518

39266

1.70

171.71

12.2

7.8

0.0

e9/l

0.27

4477

31923

(3027944) Amphetamines [Presence] in Urine

1311

5795

2.38

168.27

4.4

1.7

—

(40762366) Oxygen capacity [Volume Fraction] in Arterial blood

1004

3923

2.66

167.47

10.1

9.9

—

(40763571) Iron/Transferrin [Ratio] in Serum or Plasma

1892

9746

2.08

166.45

2.9

2.3

22.3

23.6

2.85

1605

8313

(3029879) Epithelial cells.squamous [#/volume] in Urine by Automated count

2248

12336

1.98

165.74

3.4

2.6

3.5

2.4

e6/l

3.69

1233

6472

(3027945) Reticulocytes/100 erythrocytes in Blood

1603

7801

2.18

163.27

3.1

2.5

1.9

1.7

7.63

1411

6896

(3007853) Bacteria identified in Skin by Aerobe culture

1809

9238

2.09

162.58

2.0

1.6

—

(3042936) Bacteria identified in Isolate by Culture

1990

10537

2.03

162.02

2.4

1.8

—

(3022250) Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma by Lactate to pyruvate reaction

1562

7562

2.19

161.05

3.7

3.8

241.6

u/l

0.00

1465

7141

(3051714) Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma

2759

16356

1.86

160.22

2.2

1.6

1.4

1.2

mg/l

1.71

2089

12135

(3016038) Potassium [Moles/volume] in Urine

247

356

6.97

159.62

1.4

1.6

28.9

36.4

mmol/l

4.43

202

311

(3027273) Bicarbonate [Moles/volume] in Venous blood

845

3111

2.80

157.99

4.3

3.1

25.2

25.0

mmol/l

0.91

814

3009

(3020059) Calcium [Moles/volume] corrected for albumin in Serum or Plasma

2238

12533

1.93

154.30

3.1

2.7

2.4

mmol/l

0.56

1903

10858

(3030306) Epithelial cells.non-squamous [#/volume] in Urine by Automated count

2316

13160

1.91

152.62

3.2

2.4

1.2

1.1

e6/l

0.91

1296

7269

(46236098) ABO and Rh group [Type] in Blood by Confirmatory method

3151

19704

1.78

152.16

2.8

2.0

—

(3024928) Oxygen saturation in Venous blood

508

1416

3.65

151.33

4.0

3.6

—

(3019550) Sodium [Moles/volume] in Serum or Plasma

10751

93516

2.02

150.24

25.8

11.5

138.7

139.7

mmol/l

234.04

10576

90606

(3008295) Osmolality of Serum or Plasma

327

659

5.00

149.25

1.5

1.6

276.0

283.5

mosm/kgh2o

4.65

255

524

(3015235) Bicarbonate [Moles/volume] in Capillary blood

551

1660

3.38

145.61

4.4

3.0

24.3

24.4

mmol/l

0.10

497

1456

(3008909) Norovirus RNA [Presence] in Stool by NAA with probe detection

537

1597

3.43

144.83

1.3

1.2

—

(3026910) Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma

7876

62964

1.65

144.77

5.0

2.7

67.0

42.9

u/l

47.90

7507

59071

(3046896) Herpes virus 6 DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

170

177

9.60

143.73

1.3

1.1

—

(3036489) Thrombin time

774

2875

2.77

141.96

2.9

2.1

21.5

21.4

0.26

709

2483

(3023103) Potassium [Moles/volume] in Serum or Plasma

10743

93860

1.98

141.53

25.5

11.6

3.9

4.0

mmol/l

5.75

10548

90712

(3044212) Herpes simplex virus 1+2 IgM Ab [Presence] in Cerebral spinal fluid

149

134

11.10

139.61

1.2

1.1

—

(3005785) Creatine kinase.MB [Mass/volume] in Serum or Plasma

1223

5674

2.25

138.97

2.5

2.0

6.7

8.4

ug/l

2.38

1055

4982

(3037467) Urinalysis macro (dipstick) panel - Urine

7581

60350

1.62

138.68

5.0

3.6

—

(3002823) Mycoplasma pneumoniae IgG Ab [Units/volume] in Cerebral spinal fluid

144

127

11.31

136.68

1.2

1.1

—

(42868421) Varicella zoster virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay

146

133

10.96

135.62

1.1

—

(3046279) Procalcitonin [Mass/volume] in Serum or Plasma

630

2149

3.00

135.07

2.2

1.8

2.6

2.4

ug/l

0.18

547

1884

(3004529) Oxygen [Partial pressure] adjusted to patient's actual temperature in Venous blood

760

2868

2.72

135.06

5.0

3.5

51.6

48.5

2.76

753

2823

(3037677) Mycoplasma pneumoniae IgM Ab [Titer] in Cerebral spinal fluid

145

134

10.80

133.39

1.2

1.1

—

(3020891) Body temperature

714

2627

2.79

133.19

6.6

4.4

—

(40761849) Varicella zoster virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay

140

124

11.26

132.50

1.1

—

(3011166) Borrelia burgdorferi Ab [Presence] in Cerebral spinal fluid

307

661

4.68

129.45

1.1

1.0

—

(3018405) Lactate [Moles/volume] in Arterial blood

640

2272

2.88

127.57

5.2

3.9

1.5

1.4

mmol/l

1.40

626

2241

(3042517) Benzodiazepines panel - Urine

124

12.61

126.15

3.2

2.0

—

(3019902) Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture

1467

7646

2.01

122.32

4.7

2.7

—

(40771025) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma

4609

33313

1.58

121.36

2.6

2.1

72.1

74.8

nmol/l

7.54

4181

30200

(3020460) C reactive protein [Mass/volume] in Serum or Plasma

10651

94233

1.83

114.37

22.2

9.8

24.1

23.8

mg/l

0.34

9059

70898

(3001079) Blood group antibody screen [Presence] in Serum or Plasma

5378

40649

1.54

113.85

4.5

3.6

—

(3005719) IgG [Mass/volume] in Serum or Plasma

1133

5511

2.13

113.40

2.6

2.4

10.6

10.7

g/l

0.12

1011

4994

(44816559) Phosphatidylethanol [Mass/volume] in Blood

524

1782

2.99

112.72

1.7

1.3

—

(3023520) Reticulocytes [#/volume] in Blood

1149

5637

2.12

112.42

2.8

2.5

72.7

68.8

e9/l

2.34

830

4173

(3012336) Haptoglobin [Mass/volume] in Serum or Plasma

729

2948

2.53

112.22

1.9

1.7

1.5

g/l

0.09

618

2519

(3016881) Enterovirus RNA [Presence] in Specimen by NAA with probe detection

263

563

4.69

111.66

1.4

1.5

—

(3022313) Gas panel - Capillary blood

845

3679

2.36

110.62

6.0

3.6

—

(3029187) Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Serum or Plasma

2892

19020

1.65

110.27

3.0

2.7

1535.4

1309.5

ng/l

1.55

2447

15973

(42868414) European tick borne encephalitis virus IgM Ab [Presence] in Serum by Immunoassay

163

226

7.20

109.10

1.1

—

(3048816) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Blood

1160

5784

2.08

108.56

4.7

3.2

1.2

mmol/l

18.32

1066

4968

(3043409) Potassium [Moles/volume] in Arterial blood

543

1943

2.84

106.42

5.7

4.2

3.8

3.9

mmol/l

3.28

500

1828

(3004490) Bicarbonate [Moles/volume] standard in Capillary blood

777

3337

2.39

104.78

6.2

3.7

24.4

24.6

mmol/l

0.91

750

3108

(3020630) Protein [Mass/volume] in Serum or Plasma

1033

5020

2.13

103.27

1.9

2.3

65.5

67.1

g/l

7.14

944

4539

(3021125) Hepatitis C virus RNA [Presence] in Serum or Plasma by NAA with probe detection

248

541

4.60

102.88

1.9

1.4

—

(3008402) Methanol [Moles/volume] in Serum or Plasma

14.83

101.71

1.4

1.3

—

mmol/l

—

(3043525) Herpes simplex virus Ab [Presence] in Cerebral spinal fluid

16.56

100.62

1.2

—

(3052851) Hemolysis interference index of Serum or Plasma

566

2152

2.67

98.63

3.7

2.8

—

(3021901) Oxygen saturation in Capillary blood

377

1152

3.30

97.13

3.8

2.8

—

(3035929) Mycoplasma pneumoniae Ab [Units/volume] in Cerebral spinal fluid

21.02

95.03

1.1

—

(3023365) Varicella zoster virus Ab [Titer] in Cerebral spinal fluid

15.67

94.37

1.2

1.1

—

(3001122) Ferritin [Mass/volume] in Serum or Plasma

5087

39037

1.49

94.11

3.2

2.6

132.6

111.5

ug/l

3.35

4655

36355

(3016407) Fibrinogen [Mass/volume] in Platelet poor plasma by Coagulation assay

592

2365

2.55

93.22

3.7

2.7

3.4

3.6

g/l

1.34

574

2250

(3020427) Coagulation factor X inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay

538

2079

2.63

90.68

3.6

0.3

u/ml

0.27

310

1144

(3023081) Carboxyhemoglobin/Hemoglobin.total in Blood

659

2802

2.40

90.65

6.6

4.8

1.9

1.7

3.71

622

2608

(3029536) Hepatitis C virus RNA [Units/volume] (viral load) in Specimen by NAA with probe detection

194

384

5.05

90.39

1.9

1.6

2296281.8

1432529.7

iu/ml

0.32

(3009508) Creatinine [Moles/volume] in Urine

3695

26722

1.52

90.26

4.6

3.2

7.5

8.3

mmol/l

18.14

3169

22671

(3013707) Erythrocyte sedimentation rate by Westergren method

7660

64023

1.47

89.64

4.2

3.4

12.7

10.3

mm/h

32.90

7105

59002

(3008486) Thyroxine (T4) free [Moles/volume] in Serum or Plasma

8139

68925

1.48

88.49

4.3

3.5

14.4

14.7

pmol/l

14.29

7443

62256

(3007930) Methemoglobin/Hemoglobin.total in Blood

646

2763

2.38

87.64

6.8

4.9

0.9

1.14

611

2572

(3033306) Mononuclear cells/100 leukocytes in Cerebral spinal fluid

170

314

5.41

85.62

1.4

1.3

53.0

68.5

1.10

(3017143) Hepatitis C virus Ab [Presence] in Serum

1895

11868

1.68

84.57

1.8

1.6

—

(3040370) OLANZapine [Moles/volume] in Serum or Plasma

171

322

5.30

84.32

2.3

137.3

154.2

nmol/l

0.99

148

274

(3042194) Human metapneumovirus RNA [Presence] in Specimen by NAA with probe detection

395

1356

2.94

83.39

1.7

1.5

—

(3007368) IgG [Mass/volume] in Cerebral spinal fluid

242

611

3.97

82.95

1.2

1.1

34.5

44.0

mg/l

3.29

199

508

(3000067) Parathyrin.intact [Mass/volume] in Serum or Plasma

968

4970

2.00

82.73

4.6

3.9

90.0

86.9

ng/l

0.38

851

4344

(42868415) European tick borne encephalitis virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay

105

124

8.42

80.57

1.1

—

(3040853) Adenovirus DNA [Identifier] in Specimen by NAA with probe detection

386

1336

2.91

80.29

1.8

1.5

—

(3005715) Vancomycin [Mass/volume] in Serum or Plasma

269

756

3.57

78.98

6.0

6.3

10.8

10.9

mg/l

0.12

239

699

(3002148) Methylenedioxymethamphetamine [Presence] in Urine by Screen method

246

651

3.79

78.91

4.4

1.8

—

(44816808) CXCL13 Ag [Mass/volume] in Cerebral spinal fluid

139

231

6.00

78.29

1.1

86.9

210.4

ng/l

0.91

(43055120) Cytomegalovirus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection

373

1290

2.91

77.69

5.8

5.4

543.5

671.6

iu/ml

0.20

181

(3025023) Rhinovirus RNA [Presence] in Specimen by NAA with probe detection

212

511

4.15

77.40

1.4

1.5

—

(3000515) Antithrombin actual/normal in Platelet poor plasma by Chromogenic method

584

2538

2.33

76.26

3.5

2.6

89.5

92.0

1.45

556

2372

(3035637) Corticotropin [Mass/volume] in Plasma

297

918

3.25

75.08

1.7

1.5

—

(3024474) Albumin [Mass/volume] in Cerebral spinal fluid

227

593

3.83

74.19

1.1

229.3

271.2

mg/l

2.57

199

527

(3019250) Coagulation factor VIII activity actual/normal in Platelet poor plasma by Coagulation assay

540

2295

2.38

74.17

4.0

2.5

189.9

179.8

1.76

520

2183

(3047181) Lactate [Moles/volume] in Blood

534

2265

2.39

73.67

7.6

5.5

1.4

1.2

mmol/l

1.78

473

1979

(3043849) Epstein Barr virus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection

296

925

3.21

73.49

4.2

2.8

1558.3

589.6

u/ml

0.38

(3024666) Lithium, Blood [Moles/volume] in Serum or Plasma

214

542

3.95

73.05

13.8

10.9

0.6

mmol/l

0.12

195

490

(3007164) IgA [Mass/volume] in Serum or Plasma

2546

17651

1.53

73.05

1.5

1.4

2.5

2.3

g/l

3.16

1483

10684

(3025927) Herpes simplex virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay

13.77

72.97

1.1

—

(3000570) Elastase.pancreatic [Mass/mass] in Stool

461

1837

2.53

72.82

1.5

1.4

250.6

280.2

ug/g

2.12

273

1042

(3028026) IgM [Mass/volume] in Serum or Plasma

842

4306

2.00

72.49

1.8

1.3

g/l

0.45

771

3913

(36305247) Microscopic observation [Identifier] in Isolate by Gram stain

489

2008

2.46

72.45

1.8

1.6

—

(40765161) Human bocavirus DNA [Presence] in Specimen by NAA with probe detection

290

905

3.22

72.17

1.8

1.5

—

(40759883) Oligoclonal Bands IgG [Presence] in Cerebral spinal fluid by Isoelectric focusing

219

569

3.85

72.14

1.1

—

(3013512) EKG study

3039

21926

1.49

71.84

4.2

3.4

—

(1761868) Lipid panel - Serum or Plasma

2645

35474

0.66

71.75

2.9

2.5

—

(3035350) Ketones [Presence] in Urine by Test strip

5317

42708

1.40

69.45

4.1

3.0

0.0

estimate

1.54

1099

7617

(4027681)

193

471

4.09

69.33

1.3

1.2

—

(37021073) Hepatitis C virus genotype in Serum or Plasma by Sequencing

114

7.93

66.55

1.2

1.1

—

(3009201) Thyrotropin [Units/volume] in Serum or Plasma

9443

84016

1.46

66.53

5.3

4.1

1.9

2.1

mu/l

2.51

8802

77068

(3004588) Protein electrophoresis panel - Serum or Plasma

782

4018

1.98

66.29

1.6

2.1

—

(3030692) Respiratory virus DNA+RNA [Identifier] in Specimen by NAA with probe detection

253

766

3.31

66.16

1.8

1.4

—

(3019225) pH of Specimen

1203

7097

1.75

65.72

4.5

3.5

—

(3044254) Respiratory syncytial virus RNA [Presence] in Specimen by NAA with probe detection

564

2578

2.22

65.20

1.9

1.6

—

(3011960) Natriuretic peptide B [Mass/volume] in Serum or Plasma

992

5543

1.83

65.10

3.1

2.7

216.6

183.3

ng/l

1.33

891

4986

(3009035) Cobalamin (Vitamin B12) [Moles/volume] in Serum or Plasma

2322

16134

1.52

64.93

1.7

1.6

12272950.2

34869622.5

pmol/l

2.08

1923

13456

(42868417) European tick borne encephalitis virus IgG Ab [Presence] in Serum by Immunoassay

112

7.90

64.84

1.1

—

(3009261) Glucose [Presence] in Urine by Test strip

5341

43257

1.39

64.83

4.2

3.0

0.0

estimate

0.55

1079

7581

(3044889) 12 lead EKG panel

7044

59697

1.38

64.63

4.0

3.3

—

(3011397) Hemoglobin [Presence] in Urine by Test strip

2707

19445

1.48

64.24

3.8

3.1

—

(46235355) HIV 1 and 2 tests - Meaningful Use set

2989

21893

1.46

64.16

2.2

2.0

—

(40766799) MGMT gene methylation score in Tissue by Molecular genetics method

14.38

63.75

1.1

1.0

—

(3021601) Nitrite [Presence] in Urine by Test strip

5279

42833

1.38

62.59

5.6

4.1

0.0

estimate

1.34

1132

7850

(40768797) Stomach Pathology biopsy report

1559

9982

1.62

62.21

1.3

1.2

—

(3002482) Mycoplasma pneumoniae DNA [Presence] in Specimen by NAA with probe detection

294

1014

2.91

61.54

1.6

1.4

—

(3019050) Tissue transglutaminase IgA Ab [Units/volume] in Serum

2826

20712

1.45

59.75

1.4

1.3

1.9

2.0

u/ml

0.07

675

5492

(3024403) Complement+Immunoglobulin [Units/volume] in Red Blood Cells

361

1412

2.57

59.25

1.5

—

(21494755) Public health laboratory ask at order entry panel

656

11918

0.52

58.31

1.3

—

(3012320) Pathologist interpretation of Cerebral spinal fluid tests

7.98

57.40

1.1

1.2

—

(3017766) Complement C4 [Mass/volume] in Serum or Plasma

447

1977

2.28

55.90

2.0

1.6

0.2

g/l

0.70

412

1879

(3019150) Specific gravity of Urine by Refractometry

2594

18924

1.45

55.61

4.7

3.3

1.0

kg/l

1.14

352

2858

(3024891) Influenza virus A+B Ag [Presence] in Specimen

479

2202

2.19

54.53

1.3

1.1

—

(3000620) Complement C3 [Mass/volume] in Serum or Plasma

455

2055

2.23

54.10

2.0

1.6

1.2

g/l

0.13

423

1954

(3041145) Herpes simplex virus IgM Ab [Presence] in Serum by Immunoassay

186

531

3.50

53.41

1.2

1.1

—

(3039000) Anion gap in Blood

378

1591

2.39

52.99

9.0

6.5

11.3

11.2

mmol/l

0.15

348

1416

(3018572) Chloride [Moles/volume] in Blood

378

1592

2.39

52.92

9.0

6.5

104.1

105.4

mmol/l

4.09

348

1417

(3037522) Nuclear Ab [Titer] in Serum

1576

10493

1.55

52.57

1.4

1.3

367.5

527.7

titre

5.97

294

1956

(3002385) Erythrocyte distribution width [Ratio]

8991

80424

1.38

52.17

27.7

12.5

13.7

13.5

24.53

8855

78487

(3007463) Buprenorphine [Presence] in Urine

13.99

51.95

3.9

5.0

—

(3017181) Myelocytes/100 leukocytes in Blood

1048

6334

1.69

51.91

4.5

3.9

0.9

0.03

331

1468

(3009445) Proteinase 3 Ab [Units/volume] in Serum

573

2891

2.00

50.96

1.3

1.6

4.8

15.1

u/ml

3.16

(44790047)

214

687

3.11

50.86

1.7

1.5

—

(44790049)

214

687

3.11

50.86

1.7

1.5

—

(44790048)

214

688

3.11

50.74

1.7

1.5

—

(44806118)

214

688

3.11

50.74

1.7

1.5

—

(46235759) Influenza virus B RNA [Presence] in Nasopharynx by NAA with probe detection

564

2850

2.00

49.93

2.0

1.7

—

(3031072) Herpes simplex virus 1 IgG Ab [Presence] in Cerebral spinal fluid

8.91

49.86

1.1

1.0

—

(3040151) Glucose [Moles/volume] in Capillary blood

241

838

2.88

49.75

9.4

13.7

7.0

7.4

mmol/l

0.73

202

675

(42868499) Enterovirus IgG Ab [Presence] in Cerebral spinal fluid by Immunoassay

9.15

49.25

1.1

—

(3007695) Herpes simplex virus 2 IgG Ab [Presence] in Cerebral spinal fluid

8.66

48.77

1.1

1.0

—

(3042596) Human coronavirus RNA [Presence] in Specimen by NAA with probe detection

200

633

3.15

48.70

2.0

1.5

—

(3009224) EGFR gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal

18.39

48.43

1.1

1.0

—

(3006184) Hemoglobin [Mass/volume] in Capillary blood

378

1660

2.29

48.07

2.6

2.1

131.1

132.3

g/l

0.45

303

1191

(3012984) Norclozapine [Mass/volume] in Serum or Plasma

101

7.07

47.77

7.4

8.1

—

(3030862) Granulocytes [#/volume] in Cerebral spinal fluid

192

5.12

47.35

1.4

1.2

23.7

15.1

0.48

(3045716) Anion gap in Serum or Plasma

119

270

4.38

47.14

3.1

2.4

9.5

9.7

mmol/l

0.15

197

(3008230) Borrelia burgdorferi IgM Ab [Units/volume] in Serum

883

5234

1.72

46.84

2.3

25.6

21.8

au/ml

0.37

365

(3007566) Smooth muscle Ab [Titer] in Serum

456

2186

2.10

46.60

1.2

1.3

82.6

130.0

titre

0.68

219

(3002109) Cholesterol in LDL/Cholesterol in HDL [Mass Ratio] in Serum or Plasma

589

10316

0.54

45.60

1.6

—

(3016888) Borrelia burgdorferi IgG Ab [Units/volume] in Serum

814

4768

1.73

45.03

1.2

42.9

50.5

au/ml

0.30

210

(3019284) Hepatitis B virus surface Ag [Presence] in Serum

2347

17391

1.41

44.81

1.8

1.7

—

(3043747) Beta 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

453

2211

2.06

44.12

1.7

2.0

4.0

3.9

g/l

0.59

336

1575

(3043723) Beta 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

453

2215

2.06

43.90

1.7

2.0

—

(3012477) Bordetella pertussis DNA [Presence] in Specimen by NAA with probe detection

236

868

2.72

43.87

1.5

1.3

—

(3020565) Legionella pneumophila DNA [Presence] in Specimen by NAA with probe detection

210

726

2.89

43.86

1.6

1.3

—

(3005229) Alpha 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

453

2218

2.06

43.74

1.7

2.0

7.4

7.3

g/l

1.09

346

1666

(3002179) Metamyelocytes/100 leukocytes in Blood

947

5833

1.65

43.36

4.1

3.7

0.5

0.6

0.20

240

1098

(40769539) Bacteria identified based on 16S rRNA gene [Identifier] in Specimen by Sequencing

295

1220

2.42

43.04

1.7

1.5

—

(3015322) Alpha 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

431

2085

2.08

42.99

1.7

2.1

3.2

3.0

g/l

4.21

340

1629

(3021879) Hepatitis B virus core Ab [Presence] in Serum

1169

7596

1.57

42.91

1.5

—

(3014162) Mycobacterium tuberculosis DNA [Presence] in Specimen by NAA with probe detection

432

2098

2.07

42.64

2.5

2.6

—

(3016650) Hepatitis A virus Ab [Presence] in Serum

322

1395

2.31

42.29

1.2

1.1

—

(3030366) Cystatin C [Mass/volume] in Serum or Plasma

463

2319

2.01

41.99

7.7

3.8

1.5

1.4

mg/l

2.76

431

2128

(3021440) Promyelocytes/100 leukocytes in Blood

973

6107

1.62

41.27

4.6

3.9

0.1

0.13

310

1385

(3023511) Choriogonadotropin [Units/volume] in Urine

458

2301

2.00

41.18

1.6

1.3

—

(3029937) Albumin [Presence] in Urine by Test strip

2917

22664

1.35

41.12

4.7

3.3

0.0

estimate

0.04

1044

7504

(3000494) Fungus identified in Specimen by Culture

1377

9369

1.51

40.86

1.5

1.4

—

(3023465) Gamma globulin [Mass/volume] in Serum or Plasma by Electrophoresis

421

2074

2.04

39.98

1.7

2.1

10.3

10.4

g/l

0.15

358

1736

(3011648) Oxygen content in Venous blood

175

579

3.01

39.57

5.8

3.7

11.4

11.6

0.21

175

579

(4035726)

967

6127

1.61

39.39

1.4

1.3

—

(3049804) Myeloperoxidase IgG Ab [Units/volume] in Serum

386

1859

2.08

38.97

1.3

1.5

11.1

11.3

iu/ml

—

(3051651) Icteric interference index of Serum or Plasma

143

425

3.35

38.67

4.2

3.2

—

(3035797) Protein.monoclonal band 2 [Mass/volume] in Serum or Plasma by Electrophoresis

356

1671

2.14

38.45

1.7

2.0

0.0

g/l

0.23

318

1530

(40760892) CBC W Ordered Manual Differential panel - Blood

2536

19453

1.36

38.44

5.5

3.9

—

(3009991) Angiotensin converting enzyme [Enzymatic activity/volume] in Cerebral spinal fluid

135

389

3.45

38.33

1.1

1.0

u/l

0.08

173

(3031478) Chlamydophila pneumoniae DNA [Presence] in Specimen by NAA with probe detection

209

775

2.69

38.28

1.6

1.3

—

(3029338) Protein.monoclonal band 3 [Mass/volume] in Serum or Plasma by Electrophoresis

335

1548

2.17

37.66

1.7

2.0

0.0

g/l

1.01

298

1411

(3025159) Blasts/100 leukocytes in Blood

922

5850

1.60

37.28

4.7

4.0

0.1

0.2

0.65

262

1215

(1175310) Leucine-rich glioma-inactivated protein 1 Ab [Presence] in Cerebral spinal fluid by Cell binding immunofluorescent assay

17.04

37.08

1.0

—

(3051593) INR in Capillary blood by Coagulation assay

113

296

3.79

36.97

4.4

11.2

—

(3048929) Epstein Barr virus Ab [Presence] in Serum

591

3349

1.78

36.59

1.4

1.2

—

(3006923) Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma

10771

100785

1.42

36.57

13.8

8.1

28.8

27.4

u/l

4.42

10484

97006

(40764999) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)

9347

85565

1.32

36.56

19.3

9.6

89.8

86.2

ml/min/173m2

37.23

7886

68288

(40761511) CBC panel - Blood by Automated count

10698

99990

1.41

36.49

20.0

9.7

—

(42868497) Enterovirus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay

10.42

36.06

1.1

—

(3011412) CD3 cells [#/volume] in Blood

178

628

2.82

35.88

2.8

2.4

1.2

1.3

e9/l

0.42

109

373

(3029379) Protein.monoclonal band 4 [Mass/volume] in Serum or Plasma by Electrophoresis

327

1526

2.15

35.86

1.8

2.0

0.0

g/l

0.00

296

1407

(3007844) Epstein Barr virus capsid IgM Ab [Units/volume] in Serum by Immunoassay

359

1743

2.06

35.49

1.4

1.2

—

(3007080) Epstein Barr virus nuclear IgG Ab [Units/volume] in Serum

343

1638

2.10

35.44

1.4

1.3

257.2

242.7

u/ml

0.38

200

982

(3028286) Albumin [Mass/volume] in Serum or Plasma by Electrophoresis

357

1732

2.07

35.36

1.7

2.0

36.6

38.7

g/l

6.40

313

1479

(3034770) Mitochondria Ab [Titer] in Serum

416

2136

1.95

35.15

1.2

1.3

501.3

868.9

titre

—

(3044491) Cholesterol non HDL [Mass/volume] in Serum or Plasma

380

7031

0.52

34.85

1.4

—

(3003284) Neutrophil cytoplasmic Ab.perinuclear [Titer] in Serum by Immunofluorescence

440

2309

1.91

34.85

1.5

1.6

607.3

255.7

titre

0.57

(3019977) pH of Arterial blood

121

347

3.47

34.65

3.1

2.7

7.4

0.53

122

(3000093) Morphology [Interpretation] in Blood Narrative

182

663

2.74

34.55

1.1

—

(3045156) Carbon dioxide [Partial pressure] adjusted to patient's actual temperature in Arterial blood

194

4.40

34.41

3.6

2.5

—

(3022803) Oxygen [Partial pressure] adjusted to patient's actual temperature in Arterial blood

194

4.40

34.41

3.6

2.5

—

(3014326) Insulin-like growth factor-I [Moles/volume] in Serum or Plasma

207

808

2.56

34.24

2.4

2.7

20.9

20.8

nmol/l

0.00

191

777

(3015635) Cytomegalovirus IgM Ab [Units/volume] in Serum or Plasma

330

1580

2.09

33.87

1.6

1.4

21.9

20.0

u/ml

0.11

(3021387) Prolactin [Units/volume] in Serum or Plasma

669

4013

1.68

33.75

1.8

1.6

375.4

304.9

mu/l

3.05

590

3646

(3030429) Borrelia sp DNA [Identifier] in Specimen by NAA with probe detection

239

3.99

33.75

1.1

—

(3018171) Choriogonadotropin [Units/volume] in Serum or Plasma

760

4719

1.63

33.51

2.6

2.3

7892.3

6382.7

u/l

0.53

264

1907

(3000242) Tau protein [Mass/volume] in Cerebral spinal fluid

134

420

3.17

33.30

1.0

280.4

328.0

ng/l

1.17

302

(3010130) Cytomegalovirus IgG Ab [Units/volume] in Serum or Plasma

313

1480

2.12

33.21

1.6

1.5

129.7

108.9

u/ml

1.02

308

(3042810) Amyloid beta 42 peptide [Mass/volume] in Cerebral spinal fluid

134

422

3.16

33.04

1.0

711.9

745.9

ng/l

0.32

292

(3029713) Protein.monoclonal band 1 [Mass/volume] in Serum or Plasma by Electrophoresis

377

1912

1.98

33.02

1.7

2.1

0.5

0.9

g/l

1.70

329

1630

(3003191) Choriogonadotropin (pregnancy test) [Presence] in Serum or Plasma

542

3089

1.77

32.89

2.2

1.8

—

(3013327) Hepatitis A virus IgM Ab [Presence] in Serum

294

1364

2.16

32.76

1.1

—

(3017918) Cytomegalovirus IgG Ab [Titer] in Serum or Plasma

327

1582

2.07

32.66

1.6

1.4

—

(21493690) Lymphocyte T-cell and B-cell and Natural killer subsets panel - Blood

141

463

3.03

32.39

3.2

2.0

—

(46237023) Hepatitis B virus core and surface Ab and surface Ag panel - Serum

568

3296

1.74

32.36

1.4

—

(3023601) Vancomycin resistant enterococcus [Presence] in Specimen by Organism specific culture

172

630

2.72

32.34

2.7

2.6

—

(3026989) Triiodothyronine (T3) Free [Moles/volume] in Serum or Plasma

768

4826

1.61

32.23

2.9

3.4

4.4

4.6

pmol/l

5.84

683

4329

(43055225) Phosphorylated tau 181 [Mass/volume] in Cerebral spinal fluid by Immunoassay

133

425

3.11

32.02

1.0

37.0

43.7

ng/l

1.22

302

(3011985) Renin [Units/volume] in Plasma

232

987

2.35

31.86

1.8

1.5

56.8

74.0

mu/l

0.65

206

889

(40764126) Parainfluenza virus RNA [Presence] in Specimen by NAA with probe detection

133

428

3.09

31.64

1.7

1.3

—

(3045783) Sodium and Potassium panel [Moles/volume] - Serum or Plasma

1394

9975

1.43

31.41

10.4

5.5

—

(3034780) Angiotensin converting enzyme [Enzymatic activity/volume] in Serum or Plasma

496

2797

1.78

31.21

1.7

1.8

40.7

39.0

u/l

0.98

452

2496

(40761536) Microorganisms panel - Urine sediment

1076

7339

1.49

31.15

4.9

3.2

—

(3005702) Mycobacterium sp identified in Specimen by Organism specific culture

282

1314

2.14

31.09

1.6

1.5

—

(36660697) Celiac disease serology panel - Serum

1096

7511

1.48

30.98

1.2

—

(3026250) Tacrolimus [Mass/volume] in Blood

106

304

3.46

30.40

35.4

34.1

7.1

7.3

ug/l

0.64

280

(3025271) CD3-CD16+CD56+ (Natural killer) cells [#/volume] in Blood

137

460

2.96

30.29

2.7

2.6

0.2

e9/l

0.16

110

388

(3037121) Protein [Mass/volume] in Urine

471

2643

1.79

30.14

3.4

3.3

0.4

0.3

g/l

1.16

269

1184

(3047169) Lambda light chains.free [Mass/volume] in Serum or Plasma

353

1811

1.95

29.93

2.1

3.0

45.6

46.5

mg/l

0.05

283

1461

(3034860) Kappa light chains.free [Mass/volume] in Serum

353

1813

1.95

29.83

2.1

3.0

56.6

59.4

mg/l

0.15

283

1461

(3007798) IgG/Albumin [Mass Ratio] in Cerebral spinal fluid

179

4.27

29.70

1.1

—

(3012220) Varicella zoster virus IgM Ab [Presence] in Serum by Immunoassay

277

1310

2.11

29.41

1.2

1.1

—

(3001405) CD3+CD8+ (T8 suppressor) cells [#/volume] in Blood

138

474

2.90

29.31

2.7

2.6

541.8

499.4

e6/l

0.52

111

392

(3027831) CD3-CD16+CD56+ (Natural killer) cells/100 cells in Blood

144

510

2.81

28.91

3.0

2.0

11.9

13.6

0.90

257

(1175426) CD3 cells/100 lymphocytes in Blood

144

517

2.77

28.19

3.0

2.0

73.1

71.5

0.49

139

500

(3015171) Extractable nuclear Ab [Units/volume] in Serum

477

2740

1.75

28.17

1.2

0.5

1.0

u/ml

1.16

230

(3007778) Kappa light chains/Lambda light chains [Mass Ratio] in Serum

338

1749

1.93

27.96

2.1

3.0

1.2

2.7

ratio

1.09

131

(3044242) Glucose [Moles/volume] in Arterial blood

103

307

3.33

27.85

2.2

2.1

—

(3046870) Tissue transglutaminase IgG Ab [Units/volume] in Serum

603

3721

1.63

27.21

1.1

1.3

19.9

u/ml

1.00

(3038546) Human coronavirus OC43 RNA [Presence] in Specimen by NAA with probe detection

125

426

2.92

26.97

1.3

1.5

—

(3040359) Human coronavirus NL63 RNA [Presence] in Specimen by NAA with probe detection

125

426

2.92

26.97

1.3

1.5

—

(3041642) Human coronavirus 229E RNA [Presence] in Specimen by NAA with probe detection

125

426

2.92

26.97

1.3

1.5

—

(3006245) CD3-CD19+ cells/100 cells in Blood

290

3.36

26.82

3.2

2.2

13.2

11.9

0.28

275

(1001833) Epstein Barr virus DNA [Units/volume] (viral load) in Blood by NAA with probe detection

5.73

26.10

1.7

1.2

—

(3007449) CD3+CD8+ (T8 suppressor) cells/100 cells in Blood

277

3.37

25.91

3.1

2.1

29.4

26.1

1.29

266

(3034368) Herpes virus 6 IgM Ab [Presence] in Cerebral spinal fluid

7.47

25.86

1.1

1.0

—

(3025941) Bacteria identified in Stool by Culture

724

4723

1.55

25.77

1.3

1.2

—

(37019628) Gastrointestinal bacterial pathogens panel - Stool by NAA with probe detection

295

1504

1.96

25.52

1.4

1.2

—

(3028433) Virus identified in Specimen by Culture

211

3.71

25.26

1.3

1.1

—

(3000060) B lymphocytes [#/volume] in Blood

216

3.67

25.18

3.1

2.2

712.3

617.2

e6/l

0.07

121

(42868418) European tick borne encephalitis virus IgG Ab [Presence] in Cerebral spinal fluid by Immunoassay

6.44

25.07

1.1

—

(3021197) Magnesium Ionized [Moles/volume] in Serum or Plasma

255

3.42

24.92

3.0

2.6

—

(3051611) Lipemic interference index of Serum or Plasma

177

747

2.36

24.86

4.2

2.9

—

(42529406) Shigella sp [Presence] in Stool by Culture

409

2331

1.76

24.85

1.3

1.1

—

(3037756) Immunofixation for Serum or Plasma

241

1156

2.08

24.72

1.2

1.6

—

(40757494) Bilirubin.total [Moles/volume] in Blood

113

383

2.93

24.66

1.9

2.7

44.4

71.7

umol/l

0.67

(40760888) Immunoglobulin light chains.free panel - Serum

267

1331

2.00

24.65

2.2

3.1

—

(3014765) Yersinia sp identified in Stool by Organism specific culture

406

2316

1.76

24.59

1.3

1.1

—

(3004809) Band form neutrophils/100 leukocytes in Blood

217

1002

2.16

24.58

3.5

3.1

1.6

1.3

0.28

172

778

(40761535) Cells panel - Urine sediment

893

6155

1.47

24.35

3.8

3.0

—

(3003434) Protein [Mass/volume] in Pleural fluid

190

836

2.26

24.23

1.5

33.7

33.8

g/l

0.04

171

750

(3001788) Aldosterone [Moles/volume] in Serum or Plasma

204

926

2.19

24.12

1.3

1.4

311.7

341.3

pmol/l

0.32

152

729

(3008757) Leukocyte morphology finding [Identifier] in Blood

167

697

2.38

24.06

3.6

3.2

—

(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip

3921

33412

1.23

23.97

4.5

3.1

—

(3006418) Campylobacter sp identified in Tissue by Organism specific culture

402

2304

1.75

23.96

1.3

1.1

—

(3009041) Cardiolipin IgG Ab [Units/volume] in Serum by Immunoassay

251

1240

2.02

23.78

1.4

1.2

4.6

4.3

u/ml

0.14

117

562

(3043257) Herpes virus 6 IgG Ab [Presence] in Cerebral spinal fluid

7.22

23.74

1.1

1.0

—

(3013527) Hepatitis B virus core IgM Ab [Presence] in Serum

397

2281

1.74

23.46

1.3

—

(3041354) Potassium [Moles/volume] in Venous blood

176

762

2.30

23.34

3.1

1.9

4.1

mmol/l

0.44

176

755

(3035285) Chloride [Moles/volume] in Venous blood

176

762

2.30

23.34

3.1

1.9

104.6

105.6

mmol/l

1.58

176

755

(3017509) Phencyclidine [Presence] in Urine

123

4.51

23.27

3.3

1.6

—

(3023199) Leukocytes [#/volume] in Pleural fluid

173

745

2.31

23.23

1.5

11206.1

2535.3

e6/l

0.83

125

530

(3030981) Hyaline casts [#/volume] in Urine by Automated count

619

3998

1.56

23.03

3.4

2.4

0.4

0.3

e6/l

0.78

604

3887

(3028308) Erythrocytes [#/volume] in Pleural fluid

162

681

2.37

22.99

1.5

1.4

68418.4

55275.4

e6/l

0.22

100

394

(3017315) Amylase [Enzymatic activity/volume] in Urine

104

352

2.93

22.79

1.4

1.2

261.6

435.3

u/l

0.73

324

(21494815) CD4 cells/100 lymphocytes in Specimen

148

603

2.44

22.52

2.8

2.2

45.0

44.5

0.05

(3030408) 3-Methoxytyramine [Moles/volume] in Serum or Plasma

195

904

2.15

21.92

1.3

0.2

nmol/l

0.05

(42869457) Rotavirus RNA [Identifier] in Stool by NAA with probe detection

103

355

2.88

21.86

1.4

1.2

—

(3026179) Normetanephrine [Moles/volume] in Serum or Plasma

194

901

2.14

21.71

1.3

0.6

3.7

nmol/l

1.09

184

867

(3024980) IgG subclass 4 [Mass/volume] in Serum

239

1201

1.98

21.62

1.4

1.6

0.6

0.8

g/l

3.18

183

913

(3032155) Metanephrine Free [Moles/volume] in Serum or Plasma

179

808

2.20

21.51

1.3

—

(3012202) Varicella zoster virus DNA [Presence] in Specimen by NAA with probe detection

290

3.08

21.51

1.3

1.1

—

(3012516) Albumin [Mass/volume] in Urine

2820

23409

1.25

21.51

3.6

3.3

330.7

303.7

mg/l

0.13

1913

15182

(3044355) Beta 2 glycoprotein 1 IgG Ab [Units/volume] in Serum or Plasma by Immunoassay

250

1284

1.94

21.24

1.4

1.2

4.6

3.7

u/ml

0.26

440

(3028679) Herpes simplex virus Ab [Presence] in Serum

124

479

2.57

21.14

1.2

—

(3033705) Calcium.ionized [Moles/volume] in Venous blood

168

746

2.24

21.03

3.2

1.9

—

(3041678) Intrinsic coagulation system thromboelastography panel - Blood

7.13

20.82

1.1

1.5

—

(21492711) Cytomegalovirus IgG Ab avidity [Presence] in Serum or Plasma by Immunoassay

129

512

2.50

20.80

1.3

—

(40757373) Influenza virus identified in Isolate

120

4.29

20.35

1.5

1.6

—

(3041365) Herpes simplex virus IgG Ab [Units/volume] in Serum by Immunoassay

120

4.29

20.35

1.1

—

(3020682) Albumin/Creatinine [Ratio] in Urine

2934

24588

1.23

20.30

4.5

4.0

13.7

8.2

mg/mmol

5.36

1937

16037

(42868544) Hantavirus puumala IgM Ab [Presence] in Serum or Plasma by Immunofluorescence

219

1095

1.99

20.13

1.2

1.1

—

(37020957) Sapovirus genogroups I+II+IV+V RNA [Presence] in Stool by NAA with probe detection

350

2.81

20.09

1.4

1.2

—

(3043453) Neutrophil cytoplasmic Ab.perinuclear [Titer] in Serum

144

611

2.34

20.07

1.2

170.0

202.6

titre

0.18

115

(3009340) Metanephrine [Moles/volume] in Serum or Plasma

174

800

2.16

20.01

1.3

—

nmol/l

—

(3001964) Herpes simplex virus Ag [Presence] in Specimen

199

3.44

19.77

1.4

—

(3010521) Mycoplasma pneumoniae IgM Ab [Presence] in Serum by Immunoassay

379

2277

1.66

19.06

1.2

1.1

—

(3023419) Bacteria identified in Sputum by Culture

168

778

2.15

19.00

2.6

2.5

—

(3012110) Lysozyme [Mass/volume] in Serum or Plasma

302

1712

1.76

18.78

1.9

1.8

10.2

10.4

mg/l

0.19

281

1605

(3009214) Lutropin [Units/volume] in Serum or Plasma

511

3314

1.54

18.68

1.5

1.4

8.7

8.1

u/l

0.51

404

2690

(3022756) Ceruloplasmin [Mass/volume] in Serum or Plasma

143

628

2.26

18.44

1.1

282.6

283.1

mg/l

0.03

127

564

(3010375) cycloSPORINE [Mass/volume] in Blood

296

2.88

18.37

26.6

24.7

109.1

124.1

ug/l

1.01

252

(3045788) Cell count panel - Pleural fluid

137

592

2.30

18.35

1.5

—

(3012441) Differential panel - Pleural fluid

149

669

2.21

18.22

1.5

—

(40758897) Direct antiglobulin test.IgG specific reagent [Presence] on Red Blood Cells

309

2.82

18.13

1.5

—

(40758895) Direct antiglobulin test.complement C3d specific reagent [Presence] on Red Blood Cells

309

2.82

18.13

1.5

—

(3020393) Adenovirus Ag [Presence] in Stool

4.45

18.04

1.8

1.2

—

(3001019) Free T4 and TSH panel - Serum or Plasma

318

5159

0.60

18.03

1.6

—

(3003785) Carcinoembryonic Ag [Mass/volume] in Serum or Plasma

942

6908

1.37

18.00

3.7

4.0

13.2

23.5

ug/l

1.36

776

5510

(3006804) Neuronal Ab [Presence] in Cerebral spinal fluid

7.35

17.92

1.0

—

(3050898) Methicillin resistant Staphylococcus aureus [Presence] in Genital specimen by Organism specific culture

279

2.91

17.90

2.7

2.2

—

(42868691) Thyroxine (T4) free [Moles/volume] in Serum or Plasma by Dialysis

258

3.00

17.89

1.4

1.5

12.7

14.6

pmol/l

3.11

210

(3003985) Beta hydroxybutyrate [Moles/volume] in Serum or Plasma

157

3.60

17.54

4.2

2.2

1.0

1.9

mmol/l

2.41

120

(3048689) Calprotectin [Mass/mass] in Stool

1432

11214

1.29

17.40

2.4

2.5

135.2

126.3

ug/g

0.37

1128

8897

(3031659) Enterovirus NOS Ab [Titer] in Cerebral spinal fluid

14.38

17.36

1.1

1.0

—

(3032352) Blasts [#/volume] in Cerebral spinal fluid

6.06

17.32

4.8

2.5

—

(3036180) Methadone [Presence] in Urine

28.43

17.27

4.6

2.1

—

(3040363) Hepatitis A virus IgG Ab [Presence] in Serum by Immunoassay

149

685

2.16

17.21

1.1

—

(3029493) Herpes virus 6 DNA [Presence] in Blood by NAA with probe detection

6.68

17.10

4.6

2.8

—

(3018133) Calcium [Moles/volume] in Urine

174

3.42

17.09

2.7

3.0

2.7

2.5

mmol/l

0.32

161

(3027544) Mycobacterium sp identified in Sputum by Organism specific culture

138

617

2.22

17.08

3.7

3.8

—

(3017569) Oxygen content in Arterial blood

282

2.85

16.98

2.1

2.3

—

(3022493) Free Hemoglobin [Mass/volume] in Plasma

326

2.71

16.96

3.8

4.7

103.2

1302.2

mg/l

0.77

238

(3002434) Lupus erythematosus deoxynucleoproteins IgG Ab [Units/volume] in Serum by Immunoassay

359

2193

1.63

16.95

2.0

1.8

—

(3020951) Lymphocytes/100 leukocytes in Cerebral spinal fluid

4.65

16.91

1.8

1.2

52.8

65.1

0.62

(3006922) Hepatitis E virus Ab [Presence] in Serum

132

583

2.25

16.84

1.1

—

(3015916) Alpha-1-Fetoprotein [Units/volume] in Serum or Plasma

208

1088

1.90

16.83

2.9

3.1

1926.7

451.4

u/ml

0.63

198

1010

(3037875) Bordetella parapertussis DNA [Presence] in Specimen by NAA with probe detection

289

2.81

16.81

1.9

1.3

—

(3032699) Streptococcus pneumoniae DNA [Presence] in Specimen by NAA with probe detection

328

2.69

16.76

1.9

1.3

—

(3032185) JC virus DNA [#/volume] (viral load) in Serum or Plasma by NAA with probe detection

12.00

16.66

5.4

5.1

—

(3052649) Adenosine deaminase [Enzymatic activity/volume] in Serum or Plasma

109

447

2.42

16.48

1.6

1.4

12.9

12.2

u/l

0.54

104

438

(40764127) Haemophilus influenzae DNA [Presence] in Specimen by NAA with probe detection

290

2.77

16.14

1.9

1.3

—

(3012447) Hantavirus puumala IgG Ab [Titer] in Serum

150

712

2.09

15.99

1.1

—

(3027135) IgG subclass 1 [Mass/volume] in Serum

155

745

2.07

15.99

1.4

1.3

6.8

6.6

g/l

0.15

113

512

(3016244) Insulin [Units/volume] in Serum or Plasma

132

596

2.20

15.99

4.5

3.3

26.9

29.9

mu/l

0.34

115

556

(3014271) Vancomycin [Susceptibility]

276

2.80

15.90

3.5

2.7

—

(3009595) Pneumocystis jiroveci DNA [Presence] in Specimen by NAA with probe detection

391

2.49

15.74

1.9

1.6

—

(40763082) Lactate dehydrogenase [Enzymatic activity/volume] in Pleural fluid by Lactate to pyruvate reaction

129

582

2.20

15.66

1.3

1.4

730.5

504.8

u/l

0.25

119

557

(3028192) IgG subclass 2 [Mass/volume] in Serum

154

745

2.05

15.62

1.4

1.3

2.7

3.1

g/l

1.26

113

513

(3024139) IgG subclass 3 [Mass/volume] in Serum

154

745

2.05

15.62

1.4

1.3

0.4

g/l

0.20

110

512

(3027318) Ethylene glycol [Moles/volume] in Serum or Plasma

9.89

15.56

1.1

1.0

—

mmol/l

—

(3022914) Cancer Ag 19-9 [Units/volume] in Serum or Plasma

373

2359

1.58

15.29

3.2

3.5

1960.5

1305.3

u/ml

0.21

328

2032

(3029023) Hepatitis E virus IgG Ab [Presence] in Serum by Immunoassay

120

532

2.24

15.22

1.1

—

(3005322) IgE [Units/volume] in Serum or Plasma

749

5439

1.38

15.19

1.4

1.2

329.5

268.7

u/ml

0.61

679

5058

(3006695) Toxoplasma gondii DNA [Presence] in Specimen by NAA with probe detection

4.62

15.08

2.1

—

(4062490)

152

742

2.04

15.06

1.4

1.3

—

(4306422)

226

1260

1.79

14.97

1.2

—

(3042585) Pyridoxine [Moles/volume] in Serum or Plasma

175

3.23

14.89

1.4

1.3

124.0

137.1

nmol/l

0.18

127

(3002222) Hepatitis E virus IgM Ab [Presence] in Serum

120

538

2.21

14.82

1.1

—

(3028167) CD3+CD4+ (T4 helper) cells [#/volume] in Blood

112

488

2.28

14.81

2.4

2.7

1002.7

729.5

e6/l

1.22

187

(3032836) C peptide [Moles/volume] in Serum or Plasma --fasting

289

1740

1.66

14.51

2.6

1.8

0.8

nmol/l

0.66

242

1470

(3012568) Campylobacter sp identified in Specimen by Organism specific culture

167

855

1.94

14.48

1.4

1.3

—

(46236952) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD)

836

6224

1.35

14.48

3.3

2.4

71.9

70.4

ml/min/173m2

0.42

351

2278

(4268621)

169

870

1.93

14.42

2.5

2.3

—

(42868716) Shigella species+EIEC invasion plasmid antigen H ipaH gene [Presence] in Stool by NAA with probe detection

163

829

1.95

14.41

1.4

1.3

—

(3009613) Erythrocytes [#/volume] in Peritoneal fluid

180

3.14

14.23

2.3

1.7

3378.7

8119.4

e6/l

1.03

(3036428) Adenosine deaminase [Enzymatic activity/volume] in Pleural fluid

107

466

2.28

14.19

1.3

18.9

14.4

u/l

0.44

436

(40768806) Pleura Pathology biopsy report

137

662

2.05

13.99

1.5

1.6

—

(3011363) Streptococcus pneumoniae Ag [Presence] in Urine

112

501

2.22

13.94

1.2

1.1

—

(3027238) Thyroperoxidase Ab [Units/volume] in Serum or Plasma

823

6149

1.34

13.92

1.3

1.2

116.4

150.6

iu/ml

1.22

283

2263

(3025468) Yersinia sp identified in Specimen by Organism specific culture

162

833

1.93

13.89

1.4

1.3

—

(3020148) Glutamate decarboxylase 65 Ab [Units/volume] in Serum

254

1497

1.69

13.85

1.1

93.6

7555.9

iu/ml

0.64

359

(3000504) BK virus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection

120

3.63

13.81

8.0

5.2

—

(37021247) Adenovirus 40+41 DNA [Presence] in Stool by NAA with probe detection

253

2.74

13.77

1.4

1.3

—

(37020445) Astrovirus RNA [Presence] in Stool by NAA with probe detection

253

2.74

13.77

1.4

1.3

—

(3005988) Vibrio sp identified in Specimen by Organism specific culture

162

836

1.93

13.75

1.4

1.3

—

(21493466) Plesiomonas shigelloides DNA [Presence] in Stool by NAA with non-probe detection

162

836

1.93

13.75

1.4

1.3

—

(3024869) Neuronal Ab [Presence] in Serum

104

3.81

13.45

1.1

—

(3023150) Myeloperoxidase Ab [Units/volume] in Serum

191

1048

1.81

13.40

1.2

1.3

—

(3026493) Urate [Moles/volume] in Serum or Plasma

2461

20987

1.20

13.39

3.0

2.3

3571.4

4537.9

umol/l

0.66

2096

18339

(3014148) Varicella zoster virus Ab [Titer] in Serum

222

1274

1.73

13.36

1.2

—

(3036782) Glucose [Moles/volume] in Pleural fluid

124

589

2.09

13.28

1.3

1.4

6.7

6.2

mmol/l

1.03

112

538

(3041096) Erythrocytes [Presence] in Urine by Automated

2776

23949

1.19

13.23

4.0

2.7

—

(3023487) Leukocytes [#/volume] in Peritoneal fluid

210

2.88

13.15

2.3

1.9

804.0

5076.6

e6/l

0.58

144

(3032390) JC virus DNA [#/volume] (viral load) in Urine by NAA with probe detection

8.40

13.04

5.2

3.1

—

(3022575) Varicella zoster virus IgG Ab [Units/volume] in Serum

427

2.28

13.02

1.2

1.1

1394.7

1470.8

miu/ml

0.27

427

(3020287) Protein C actual/normal in Platelet poor plasma by Coagulation assay

211

1208

1.74

12.83

1.1

117.3

114.7

0.56

190

1093

(3024522) Salmonella sp identified in Specimen by Organism specific culture

159

836

1.89

12.79

1.4

1.3

—

(3003752) BK virus DNA [Units/volume] (viral load) in Urine by NAA with probe detection

8.00

12.55

5.2

3.0

—

(3012920) Ethanol [Mass/volume] in Serum or Plasma

8.00

12.55

1.2

1.4

—

(3041293) ARIPiprazole [Mass/volume] in Serum or Plasma

6.96

12.48

2.1

2.2

—

(4010399)

766

5757

1.33

12.45

1.5

1.4

—

(3001186) Copper [Moles/volume] in Serum or Plasma

195

2.89

12.45

1.3

1.2

16.4

16.6

umol/l

0.14

173

(3013784) Calcium.ionized [Moles/volume] in Serum or Plasma by Ion-selective membrane electrode (ISE)

139

3.28

12.39

1.3

—

(3002331) Protein [Mass/volume] in Peritoneal fluid

115

3.53

12.38

1.2

1.5

22.0

25.1

g/l

0.59

(40770918) von Willebrand factor (vWf).activity actual/normal in Platelet poor plasma by Immunoassay

369

2.34

12.33

4.1

2.2

149.9

131.3

1.09

344

(43055222) Platelet function.collagen + Adenosine diphosphate induced and EPINEPHrine induced panel - Blood

102

3.69

12.24

1.6

1.3

—

(3042631) Mycobacterium sp identified in Specimen

154

816

1.87

12.12

2.2

2.8

—

(3039429) Cortisol [Moles/volume] in Saliva (oral fluid)

336

2.39

12.07

1.3

1.6

2.2

9.8

nmol/l

0.55

277

(44816844) Macroprolactin [Units/volume] in Serum or Plasma

216

1267

1.70

12.06

1.8

1.6

—

(3042847) Granulocytes/100 leukocytes in Cerebral spinal fluid

5.27

12.06

1.6

1.1

21.0

8.6

—

(3022907) Direct antiglobulin test.polyspecific reagent [Presence] on Red Blood Cells

152

3.13

11.99

1.2

1.1

—

(3028717) Thiamine [Mass/volume] in Blood

4.24

11.68

1.2

—

(3014037) CD3+CD4+ (T4 helper) cells/100 cells in Blood

366

2.30

11.66

3.0

2.6

41.8

40.3

0.29

123

(3017354) Segmented neutrophils/100 leukocytes in Blood

122

606

2.00

11.64

3.1

3.0

60.7

56.6

1.08

395

(21491979) Prolactin monomeric [Units/volume] in Serum or Plasma

393

2.24

11.51

1.3

1.5

491.3

492.4

mu/l

0.00

377

(3021952) Alkaline phosphatase isoenzymes [Enzymatic activity/volume] in Serum or Plasma by Heat stability

177

996

1.77

11.48

1.2

1.3

—

(3017895) Helicobacter pylori Ab [Units/volume] in Serum

438

3045

1.44

11.47

1.7

—

(3039443) Prostate specific Ag panel - Serum or Plasma

111

2124

0.51

11.41

1.5

1.6

—

(3031309) Prolactin monomeric/Prolactin.total in Serum or Plasma

401

2.22

11.40

1.3

1.5

72.9

72.1

0.32

385

(43055361) Metamyelocytes/Leukocytes [Pure number fraction] in Blood by Manual count

256

2.55

11.37

4.2

3.3

—

(3044007) Cell count panel - Peritoneal fluid

168

2.95

11.31

1.9

1.8

—

(3006576) Bicarbonate [Moles/volume] in Blood

269

2.50

11.25

5.5

5.7

25.3

24.8

mmol/l

0.39

245

(3023323) Follitropin [Units/volume] in Serum or Plasma

554

4026

1.38

11.23

1.5

1.4

22.6

22.4

iu/l

0.05

431

3409

(3049233) Organic acids panel - Urine

7.00

11.22

1.4

1.2

—

(3022192) Triglyceride [Mass/volume] in Serum or Plasma

254

2.53

11.04

2.9

2.1

—

(3032057) Clostridioides difficile [Presence] in Stool

115

3.36

10.95

1.9

1.8

—

(3019539) Treponema pallidum Ab [Titer] in Serum by Hemagglutination

206

1226

1.67

10.93

1.7

1.8

720.0

1825.8

titre

—

(3037692) Legionella sp identified in Specimen by Organism specific culture

177

2.85

10.90

1.6

1.5

—

(3049539) Genetic diseases [Identifier] in Blood or Tissue by FISH Nominal

385

2.21

10.79

1.2

—

(3026285) Alpha 1 antitrypsin [Mass/volume] in Serum or Plasma

188

1096

1.70

10.79

1.1

1.6

1.5

g/l

3.02

168

989

(46235128) Lupus anticoagulant aPTT and dRVVT screening panel W Reflex

443

2.13

10.77

1.3

1.2

—

(3003510) Neisseria gonorrhoeae DNA [Presence] in Urine by NAA with probe detection

1780

15015

1.20

10.69

2.3

2.1

—

(3004716) Salmonella sp identified in Stool by Organism specific culture

689

5236

1.32

10.39

1.4

—

(36204005) Streptococcus pneumoniae Danish serotype 19F IgG Ab [Mass/volume] in Serum

4.41

10.26

1.8

1.7

5.3

3.7

mg/l

0.32

(3005665) Streptococcus pneumoniae Danish serotype 6B IgG Ab [Mass/volume] in Serum

4.41

10.26

1.8

1.7

2.4

1.9

mg/l

0.13

(36204286) Streptococcus pneumoniae Danish serotype 5 IgG Ab [Mass/volume] in Serum

4.41

10.26

1.8

1.7

2.1

2.0

mg/l

0.03

(36204187) Streptococcus pneumoniae Danish serotype 4 IgG Ab [Mass/volume] in Serum

4.41

10.26

1.8

1.7

3.0

1.1

mg/l

0.47

(3006665) Streptococcus pneumoniae Danish serotype 18C IgG Ab [Mass/volume] in Serum

4.41

10.26

1.8

1.7

2.8

1.3

mg/l

0.57

(3005260) Streptococcus pneumoniae Danish serotype 9V IgG Ab [Mass/volume] in Serum

4.41

10.26

1.8

1.7

2.4

0.6

mg/l

0.65

(36204094) Streptococcus pneumoniae Danish serotype 23F IgG Ab [Mass/volume] in Serum

4.41

10.26

1.8

1.7

2.5

mg/l

0.01

(36203922) Streptococcus pneumoniae Danish serotype 14 IgG Ab [Mass/volume] in Serum

4.41

10.26

1.8

1.7

3.9

3.7

mg/l

0.06

(3010566) Parathyrin.intact [Moles/volume] in Serum or Plasma

212

1293

1.63

10.26

4.3

3.2

—

(3027653) Mycophenolate [Mass/volume] in Serum or Plasma

4.56

10.26

6.5

3.5

2.2

2.6

mg/l

0.26

(3003245) Complement C1 esterase inhibitor [Mass/volume] in Serum or Plasma

212

2.62

10.18

1.4

1.2

0.3

g/l

0.84

169

(3003265) Liver kidney microsomal Ab [Titer] in Serum by Immunofluorescence

135

728

1.84

10.14

1.2

1.4

—

(36203821) Streptococcus pneumoniae Danish serotype 1 IgG Ab [Mass/volume] in Serum

4.34

10.04

1.8

1.7

1.4

mg/l

0.09

(3028369) Herpes simplex virus 1+2 DNA [Presence] in Specimen by NAA with probe detection

154

868

1.76

10.00

1.3

1.1

—

(3027450) Sjogrens syndrome-B extractable nuclear Ab [Units/volume] in Serum

292

1929

1.51

9.98

1.3

27.2

35.7

u/ml

0.27

113

(3015816) F5 gene p.Arg506Gln [Presence] in Blood or Tissue by Molecular genetics method

210

1288

1.62

9.95

1.1

—

(3014959) Toxoplasma gondii IgG Ab [Units/volume] in Serum

170

987

1.71

9.94

2.3

2.6

—

(43055514) Macroprolactin [Presence] in Serum or Plasma

298

2.33

9.92

1.3

1.5

—

(40768446) Kidney Pathology biopsy report

317

2.28

9.89

2.1

1.6

—

(3052592) Norovirus Ag [Presence] in Stool

123

3.14

9.87

1.2

1.3

—

(3024471) HLA-A [Type]

229

2.51

9.70

1.0

—

(3042733) HLA Ab [Presence] in Serum

247

2.45

9.67

4.1

4.9

—

(3020229) Cytomegalovirus DNA [Presence] in Specimen by NAA with probe detection

135

3.01

9.66

1.1

—

(3024950) Chlamydia trachomatis DNA [Presence] in Urine by NAA with probe detection

1922

16466

1.18

9.60

2.4

2.2

—

(3030313) Adrenal Ab [Titer] in Serum

3.72

9.54

1.2

1.1

—

(3018921) Toxoplasma gondii IgA Ab [Units/volume] in Serum

323

2.24

9.48

1.2

—

(3023939) Sjogrens syndrome-A extractable nuclear Ab [Units/volume] in Serum

229

1453

1.57

9.43

1.3

1.2

47.3

40.0

u/ml

0.31

117

(3019420) Tryptase [Mass/volume] in Serum or Plasma

401

2.10

9.41

1.7

1.5

14.5

7.6

ug/l

0.68

360

(3020629) Protein S Free Ag actual/normal in Platelet poor plasma by Immunoassay

154

885

1.73

9.37

1.1

97.7

96.8

0.17

145

830

(3027529) Toxoplasma gondii IgM Ab [Units/volume] in Serum

159

923

1.71

9.33

1.2

1.3

—

(3013727) Leukocytes other/100 leukocytes in Blood

210

2.55

9.33

4.6

3.4

46.9

51.2

0.70

197

(3016921) Smith extractable nuclear Ab [Units/volume] in Serum

267

1758

1.51

9.30

1.3

3.8

4.1

u/ml

0.07

177

(3006999) Ribonucleoprotein extractable nuclear Ab [Units/volume] in Serum

270

1783

1.51

9.28

1.3

4.5

10.5

u/ml

2.21

276

(3008116) Ketones [Moles/volume] in Urine by Test strip

160

2.78

9.26

1.8

1.4

—

(42529201) Cancer Ag 19-9 [Units/volume] in Serum or Plasma by Immunoassay

210

1315

1.59

9.17

3.0

3.4

342.4

875.2

u/ml

0.55

194

1207

(3029634) Reagin Ab [Titer] in Serum by VDRL

228

1456

1.56

9.15

2.1

2.0

7.5

titre

—

(3035400) Alkaline phosphatase.liver [Enzymatic activity/volume] in Serum or Plasma

380

2.11

9.11

1.1

1.2

118.2

81.1

u/l

1.40

325

(3025059) Transferrin.carbohydrate deficient [Mass/volume] in Serum or Plasma

3.90

9.11

1.5

1.1

48.0

48.4

mg/l

—

(3024932) HLA-DR beta [Type]

231

2.44

9.05

1.0

1.1

—

(3013336) Amino acids [Identifier] in Serum or Plasma

4.21

8.93

1.6

2.5

—

(3001784) Prostate Specific Ag Free/Prostate specific Ag.total in Serum or Plasma

2296

25505

0.86

8.88

3.8

4.0

21.6

21.9

0.49

953

11733

(3019601) Blood group antibody investigation [Interpretation] in Plasma or RBC

117

631

1.84

8.85

1.8

1.7

—

(3035880) pH of Pleural fluid

333

2.17

8.83

1.3

—

(3033799) Differential panel - Peritoneal fluid

176

2.64

8.78

1.8

1.9

—

(3042111) Morphology [Interpretation] in Bone marrow Narrative

160

948

1.68

8.74

1.9

1.5

—

(3019083) Insulin-like growth factor [Moles/volume] in Serum or Plasma

139

2.85

8.60

1.7

1.6

—

(3026389) Candida sp identified in Specimen by Organism specific culture

185

1143

1.61

8.58

1.5

1.3

—

(3026692) Albumin [Mass/volume] in Peritoneal fluid

145

2.80

8.54

2.0

1.4

10.4

12.7

g/l

0.88

113

(3045684) Alkaline phosphatase.other fractions [Enzymatic activity/volume] in Serum or Plasma

371

2.08

8.50

1.1

1.2

32.4

19.5

u/l

1.01

309

(40768804) Tissue Pathology biopsy report

3735

33812

1.13

8.48

2.1

1.9

—

(40759040) C peptide [Moles/volume] in Serum or Plasma --post meal

125

698

1.78

8.45

1.5

1.3

1.2

1.4

nmol/l

1.10

113

623

(3005013) Prostate Specific Ag Free [Mass/volume] in Serum or Plasma

1633

18555

0.85

8.43

2.8

2.9

0.7

0.8

ug/l

1.40

1108

11612

(3018562) Neutrophils/100 leukocytes in Cerebral spinal fluid

4.70

8.42

1.9

1.3

43.3

29.5

0.54

(3013924) Clostridium tetani IgG Ab [Units/volume] in Serum

3.89

8.41

1.3

1.1

—

(40760109) Toxoplasma gondii IgG Ab avidity [Ratio] in Serum by Immunoassay

335

2.13

8.32

1.2

—

(3014373) Corynebacterium diphtheriae Ab [Units/volume] in Serum

4.10

8.27

1.2

—

(3017044) Thyrotropin receptor Ab [Units/volume] in Serum

284

1944

1.45

8.20

1.9

3.5

4.6

iu/l

1.61

732

(3045066) Thymidine kinase [Enzymatic activity/volume] in Serum

127

2.88

8.15

1.4

1.9

66.5

21.3

u/l

0.47

116

(3003327) Ova and parasites identified in Stool by Light microscopy

404

2951

1.36

8.03

1.7

1.6

—

(3002348) Coagulation factor XII activity actual/normal in Platelet poor plasma by Coagulation assay

173

2.57

8.01

1.2

1.1

67.6

70.9

—

(42529215) Follitropin [Units/volume] in Serum or Plasma by Immunoassay

196

1252

1.55

7.92

1.4

1.3

19.7

20.1

u/l

0.06

154

1041

(3023420) DNA double strand Ab [Units/volume] in Serum

140

824

1.69

7.89

1.6

1.5

19.7

30.3

iu/ml

0.66

(3032641) Amino acids panel - Urine

6.98

7.86

1.2

—

(3009542) Hematocrit [Volume Fraction] of Blood

9527

91225

1.13

7.81

25.0

11.1

39.0

40.5

54.98

6858

70112

(3013566) Clostridioides difficile [Presence] in Stool by Organism specific culture

236

2.31

7.75

1.3

1.1

—

(3021584) Pregnancy associated plasma protein A [Units/volume] in Serum or Plasma

544

6852

0.77

7.71

1.5

—

(3018559) Microscopic observation [Identifier] in Buccal smear by Cyto stain

138

816

1.68

7.66

1.2

1.1

—

(3004409) Coagulation factor X activity actual/normal in Platelet poor plasma by Coagulation assay

250

2.26

7.64

1.2

1.1

78.0

91.8

1.74

115

(3003694) ABO and Rh group [Type] in Blood

3159

28458

1.13

7.61

1.5

—

(3018993) Complement total hemolytic CH100 [Units/volume] in Serum or Plasma

166

2.56

7.61

1.7

1.2

—

(3027545) Mycoplasma pneumoniae Ab [Presence] in Serum by Immunoassay

347

2497

1.38

7.60

1.3

—

(3016251) Hemoglobin.gastrointestinal [Presence] in Stool

496

3768

1.31

7.58

2.3

2.4

—

(3004410) Hemoglobin A1c/Hemoglobin.total in Blood

8573

81630

1.12

7.53

5.9

5.0

39.8

39.1

mmol/mol

6.97

7971

75953

(3023602) Cholesterol in HDL [Moles/volume] in Serum or Plasma

8898

90652

0.89

7.46

4.2

3.9

1.4

mmol/l

2.64

8194

84400

(3024135) Streptococcus.beta-hemolytic [Presence] in Throat by Organism specific culture

2336

20668

1.14

7.44

1.8

1.6

—

(3021614) Rheumatoid factor [Units/volume] in Serum or Plasma

1560

13403

1.17

7.43

1.3

1.2

27.6

34.1

iu/ml

1.10

443

4160

(3006257) Acetylcholine receptor Ab [Moles/volume] in Serum

353

2.02

7.30

1.1

0.4

11.8

nmol/l

2.04

(3006441) Cardiolipin IgM Ab [Presence] in Serum by Immunoassay

268

2.18

7.29

1.2

1.1

—

(3025245) SCL-70 extractable nuclear Ab [Units/volume] in Serum by Immunoassay

215

1429

1.49

7.26

1.3

1.2

6.8

3.4

u/ml

0.30

107

(3041870) Hepatitis C virus IgG Ab [Presence] in Serum or Plasma by Immunoassay

114

2.86

7.23

1.0

1.1

—

(3001850) Coagulation factor XI activity actual/normal in Platelet poor plasma by Coagulation assay

172

2.47

7.10

1.1

72.0

81.1

—

(37021550) Renin [Units/volume] in Plasma --upright

139

2.63

6.94

1.2

1.3

58.8

50.8

mu/l

0.15

103

(3009804) Carcinoembryonic Ag [Mass/volume] in Pleural fluid

174

2.44

6.94

1.3

3.7

302.8

ug/l

1.33

(3005353) Prothrombin activity actual/normal in Platelet poor plasma by Coagulation assay

261

2.16

6.92

1.1

79.4

91.8

1.63

116

(3052318) Alpha-1-Microglobulin [Mass/volume] in Urine

128

2.70

6.91

2.6

2.8

21.1

29.3

mg/l

—

(3022621) pH of Urine by Test strip

672

5371

1.25

6.87

3.3

2.5

—

(40760007) HIV 1+2 Ab+HIV1 p24 Ag [Presence] in Serum or Plasma by Immunoassay

108

2.84

6.71

1.1

—

(3020073) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Specimen

183

2.38

6.70

3.0

1.8

—

(3027456) Digoxin [Moles/volume] in Serum or Plasma

171

1105

1.54

6.64

3.3

2.8

0.8

nmol/l

0.12

125

827

(3044941) Cell count panel - Synovial fluid

170

1100

1.53

6.56

1.4

—

(40762119) U1 small nuclear ribonucleoprotein 70kD Ab [Units/volume] in Serum

547

1.76

6.46

1.1

—

55.6

—

(3023383) Lactate [Moles/volume] in Pleural fluid

205

2.27

6.44

1.5

1.3

4.1

3.4

mmol/l

0.35

191

(21494814) CD8 cells/100 lymphocytes in Specimen

245

2.14

6.32

2.7

2.0

—

(3039162) Centromere protein B Ab [Units/volume] in Serum

140

876

1.58

6.29

1.2

1.3

32.3

52.2

u/ml

—

(3001467) Alkaline phosphatase.bone [Enzymatic activity/volume] in Serum or Plasma

116

694

1.66

6.24

1.1

1.2

61.2

72.7

u/l

0.77

445

(3009306) Alpha-1-Fetoprotein [Mass/volume] in Serum or Plasma

171

2.37

6.23

2.2

3.3

—

(3027923) C peptide [Moles/volume] in Serum or Plasma

427

1.83

6.08

1.7

1.6

1.3

1.2

nmol/l

0.42

336

(3008536) Aspergillus sp Ab [Presence] in Serum

2.83

6.04

1.4

2.3

—

(3018658) Beta 2 glycoprotein 1 IgG Ab [Units/volume] in Serum

379

1.88

6.02

1.2

1.1

24.0

26.6

u/ml

—

(42868647) JC virus Ab [Presence] in Serum or Plasma by Immunoassay

132

2.55

6.02

1.7

2.7

—

(3033086) Enterovirus NOS Ab [Titer] in Serum

5.72

6.00

1.0

1.1

—

(3016228) CD19 cells/100 cells in Blood

251

2.09

5.97

2.8

2.0

11.0

9.2

0.34

245

(3016724) Homocysteine [Moles/volume] in Serum or Plasma

100

584

1.70

5.92

1.2

1.5

13.0

11.9

umol/l

0.85

556

(3045142) Bone marrow Pathology biopsy report

102

599

1.69

5.91

1.4

1.2

—

(46235760) Methicillin resistant Staphylococcus aureus [Presence] in Pharynx by Organism specific culture

3.54

5.90

2.2

2.0

—

(3035320) C reactive protein [Mass/volume] in Body fluid

103

608

1.68

5.86

2.6

2.1

—

(3044936) Clostridioides difficile toxin A+B [Presence] in Stool by Immunoassay

134

2.51

5.85

1.1

—

(42869593) Oxyhemoglobin/Hemoglobin.total [Pure mass fraction] in Capillary blood

111

2.67

5.84

2.5

2.1

—

(3050129) First trimester maternal screen panel - Serum or Plasma

354

4532

0.76

5.76

1.5

1.4

—

(3025839) Triglyceride [Moles/volume] in Serum or Plasma

2485

22391

1.12

5.75

1.7

1.6

1.4

mmol/l

1.37

2134

19027

(3041942) Cyclic citrullinated peptide Ab [Units/volume] in Serum

1440

12536

1.15

5.73

1.3

1.2

9.5

12.6

u/ml

1.11

488

5020

(706163) SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection

7229

68644

1.10

5.72

3.5

3.2

—

(3017732) Neutrophils [#/volume] in Blood

717

5888

1.21

5.72

3.8

2.6

4.1

4.2

e9/l

0.10

556

4696

(3014038) Collagen crosslinked N-telopeptide [Moles/volume] in Urine

2.87

5.58

1.6

1.7

—

(40757349) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Blood

200

2.18

5.52

1.8

3.3

—

(3019900) Cholesterol [Moles/volume] in Serum or Plasma

9012

91320

0.91

5.47

4.3

3.9

4.5

4.7

mmol/l

37.14

8327

85446

(3018387) Mycoplasma pneumoniae IgG Ab [Units/volume] in Serum

204

1424

1.42

5.46

1.1

10.1

10.2

au/ml

—

(3004451) EKG impression Narrative

301

1.94

5.45

1.3

1.2

—

(3034426) Prothrombin time (PT)

274

1.99

5.44

1.3

1.2

—

(3049717) Cytology report of Urine Cyto stain

359

2742

1.30

5.39

2.4

2.8

—

(36304997) Mycobacterium tuberculosis stimulated gamma interferon release by CD4+ and CD8+ T-cells [Units/volume] in Blood

346

2631

1.31

5.37

1.6

58.9

3.9

iu/ml

0.70

530

(3003329) Lymphocytes/100 leukocytes in Synovial fluid

106

646

1.63

5.37

1.6

1.5

31.6

31.9

0.02

396

(3006262) Parainfluenza virus 3 RNA [Presence] in Specimen by NAA with probe detection

262

2.00

5.36

1.3

1.6

—

(3012158) Parainfluenza virus 2 RNA [Presence] in Specimen by NAA with probe detection

262

2.00

5.36

1.3

1.6

—

(3025634) Parainfluenza virus 1 RNA [Presence] in Specimen by NAA with probe detection

262

2.00

5.36

1.3

1.6

—

(3038297) Parainfluenza virus 4 RNA [Presence] in Specimen by NAA with probe detection

262

2.00

5.36

1.3

1.6

—

(3018301) Testosterone Free [Moles/volume] in Serum or Plasma

1057

0.54

5.34

1.3

51.0

69.2

pmol/l

0.61

291

(3003171) Aldosterone [Moles/volume] in Serum or Plasma --upright

159

2.30

5.31

1.1

1.2

354.2

303.5

pmol/l

0.26

116

(40759836) Histone Ab [Presence] in Serum by Immunoblot

523

1.69

5.20

1.2

1.1

—

(43533860) Galactose-alpha-1,3-galactose (Alpha-Gal) IgE Ab [Units/volume] in Serum

101

2.64

5.18

1.1

0.0

0.4

u/ml

0.79

(40759812) SCL-70 extractable nuclear Ab [Presence] in Serum by Immunoblot

524

1.68

5.17

1.2

1.1

—

(3048518) aPTT.lupus sensitive actual/normal (normalized LA screen)

502

1.70

5.16

1.2

1.1

ratio

0.64

177

(40759844) Sjogrens syndrome-B extractable nuclear Ab [Presence] in Serum by Immunoblot

532

1.68

5.15

1.2

1.1

—

(3021788) Differential panel - Synovial fluid

187

1300

1.43

5.14

1.6

1.5

—

(42870365) C reactive protein [Mass/volume] in Blood by High sensitivity method

139

913

1.51

5.11

2.4

1.9

33.3

28.1

mg/l

0.40

234

(43534045) MCM6 gene c.-13910C>T and -13915T>G [Identifier] in Blood or Tissue by Molecular genetics method Nominal

645

5304

1.21

5.10

1.1

1.0

—

(40759849) Smith extractable nuclear Ab [Presence] in Serum by Immunoblot

526

1.68

5.10

1.2

1.1

—

(3048773) Triglyceride [Moles/volume] in Serum or Plasma --fasting

8619

87404

0.91

4.98

3.9

3.5

1.3

mmol/l

5.95

7907

80998

(3013945) Hepatitis B virus e Ab [Presence] in Serum

3.71

4.98

1.4

2.1

—

(21494890) Protein electrophoresis panel - 24 hour Urine

598

1.62

4.97

1.4

2.0

—

(3036669) Protein S actual/normal in Platelet poor plasma by Coagulation assay

383

1.78

4.95

1.1

96.9

94.1

0.31

306

(40759843) Sjogrens syndrome-A extractable nuclear Ab [Presence] in Serum by Immunoblot

531

1.66

4.94

1.2

1.1

—

(40759842) Ribonucleoprotein extractable nuclear Ab [Presence] in Serum by Immunoblot

532

1.66

4.90

1.2

1.1

—

(40760848) Basement membrane zone BP180 Ab [Units/volume] in Serum by Immunoassay

450

1.72

4.90

1.5

1.6

26.2

23.0

u/ml

0.24

105

(3015479) Mycobacterium sp identified in Blood by Organism specific culture

2.92

4.86

1.4

—

(40763531) Fetal Nuchal fold [Multiple of the median] Thickness adjusted for maternal weight

275

3552

0.76

4.84

1.4

—

(46235831) Pregnancy associated plasma protein A [Multiple of the median] adjusted in Serum or Plasma

275

3551

0.76

4.84

1.4

—

(3002619) Bacteria identified in Specimen by Culture

160

2.23

4.81

1.3

1.2

—

(3000475) Leukocytes [#/volume] in Synovial fluid

232

1694

1.36

4.80

1.7

1.6

13617.4

13807.4

e6/l

0.03

161

1243

(3020961) Endomysium IgA Ab [Titer] in Serum

556

4535

1.22

4.80

1.1

70.4

256.3

titre

3.46

154

(3019145) Choriogonadotropin.beta subunit free [Mass/volume] in Serum or Plasma

301

3836

0.77

4.80

1.4

1.5

—

(40771922) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood

3.18

4.77

1.3

1.0

1.2

ml/s/173m2

0.38

(3035544) Cardiolipin IgG Ab [Units/volume] in Serum or Plasma

260

1.94

4.77

1.2

1.1

—

(4024509)

109

690

1.56

4.77

1.6

1.5

—

(42529188) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma by Immunoassay

2.74

4.74

1.3

1.0

—

(3017446) Testosterone [Moles/volume] in Serum or Plasma

984

8449

1.16

4.74

2.3

2.1

12.6

12.8

nmol/l

0.26

831

7608

(3020047) Haemophilus influenzae B Ab [Mass/volume] in Serum

8.89

4.74

1.4

1.2

—

(3049207) Fetal Trisomy 21 risk [Likelihood] Based on maternal age

276

3547

0.76

4.70

1.4

—

(3012565) Volume of 24 hour Urine

375

1.77

4.69

1.8

2.3

2103.8

1996.4

0.19

341

(3050099) BK virus DNA [#/volume] (viral load) in Specimen by NAA with probe detection

4.53

4.69

2.5

3.8

—

(3001308) Cholesterol in LDL [Moles/volume] in Serum or Plasma

9162

92575

0.91

4.68

4.7

4.3

2.6

2.8

mmol/l

49.04

8424

86006

(3044927) Protein electrophoresis panel - Urine

585

1.61

4.67

1.2

1.1

—

(3013603) Prostate specific Ag [Mass/volume] in Serum or Plasma

3008

31849

0.91

4.66

4.2

4.6

2.5

2.7

ug/l

0.38

2634

28731

(3008714) Choriogonadotropin [Multiple of the median] adjusted in Serum or Plasma

275

3531

0.76

4.65

1.4

—

(3006442) Creatine [Moles/volume] in Serum or Plasma

565

1.61

4.58

1.7

1.4

69.3

72.8

umol/l

—

(3027953) Aldolase [Enzymatic activity/volume] in Serum or Plasma

372

1.76

4.53

1.6

1.5

9.6

6.3

u/l

0.47

320

(3000330) Specific gravity of Urine by Test strip

482

3905

1.23

4.47

3.7

2.8

—

(3007461) Platelets [#/volume] in Blood

11180

108899

1.14

4.42

32.7

15.0

251.5

251.2

e9/l

0.17

10968

105642

(3023421) Hepatitis B virus surface Ab [Units/volume] in Serum

451

3635

1.23

4.40

1.3

229.8

231.4

miu/ml

0.03

177

1787

(3006093) Chlamydia trachomatis DNA [Presence] in Specimen by NAA with probe detection

1077

9365

1.15

4.38

2.2

2.1

—

(3043870) Heparin induced platelet Ab [Units/volume] in Serum

3.11

4.38

1.1

1.3

—

(1761482) Bacteria [#/volume] in Urine by Culture

252

1897

1.32

4.30

4.3

3.1

—

(3019897) Erythrocyte distribution width [Ratio] by Automated count

1387

0.65

4.24

2.8

2.3

13.2

13.1

0.44

1368

(3029790) Creatine kinase.MB [Enzymatic activity/volume] in Serum or Plasma

3.16

4.23

1.2

1.1

13.6

14.4

u/l

0.04

(21493195) Respiratory pathogens DNA and RNA tested for in Respiratory system specimen by NAA with probe detection

196

2.02

4.22

1.4

1.8

—

(21492888) Glucose tolerance 2 hours gestational panel - Serum or Plasma

234

3023

0.76

4.18

1.8

—

(3047352) Trisomy 18 risk [Likelihood] in Fetus

219

2850

0.75

4.13

1.4

—

(3033942) Copper [Moles/time] in 24 hour Urine

3.57

4.11

1.1

1.3

0.4

0.6

umol/24h

—

(3035941) MCH [Entitic mass]

11184

109004

1.13

4.11

32.5

14.9

30.4

30.2

18.98

11074

107284

(3005033) Fetal Nuchal fold Thickness US

219

2845

0.76

4.09

1.4

—

(3024731) MCV [Entitic volume]

11184

109011

1.13

4.07

32.6

15.0

90.8

90.3

21.99

11074

107288

(3043238) Trisomy 21 risk [Likelihood] in Fetus

226

2921

0.76

4.07

1.4

1.5

—

(3048402) Erythrocytes [#/area] in Urine sediment by Automated count

430

1.66

4.05

2.2

1.7

1.8

2.9

u/field

0.49

313

(3000108) Respiratory syncytial virus B RNA [Presence] in Specimen by NAA with probe detection

194

1.99

3.97

1.4

1.8

—

(3005156) Respiratory syncytial virus A RNA [Presence] in Specimen by NAA with probe detection

194

1.99

3.97

1.4

1.8

—

(3051014) Leukocytes [#/area] in Urine sediment by Automated count

626

1.53

3.97

2.6

1.8

2.2

1.7

u/field

0.48

277

(3003338) MCHC [Mass/volume]

8842

85247

1.08

3.96

29.4

12.8

333.9

333.7

g/l

0.92

8772

84487

(3026361) Erythrocytes [#/volume] in Blood

11184

109035

1.13

3.96

32.7

15.0

4.4

4.6

e12/l

198.71

10935

105484

(3026926) Nortriptyline [Moles/volume] in Serum or Plasma

6.35

3.94

2.2

1.5

252.8

305.1

nmol/l

—

(3001684) Respiratory syncytial virus Ag [Presence] in Specimen

308

1.77

3.91

1.3

1.1

—

(3010813) Leukocytes [#/volume] in Blood

11186

109067

1.13

3.90

32.7

15.0

7.1

6.7

e9/l

30.31

10941

105484

(1176173) BK virus + JC virus DNA [Presence] in Specimen by NAA with probe detection

3.88

3.89

1.5

5.5

—

(3045414) Leukocytes [Presence] in Urine

446

3641

1.22

3.89

1.8

1.7

—

(3042975) Streptococcus sp identified in Isolate by Organism specific culture

117

789

1.47

3.89

1.2

—

(3000963) Hemoglobin [Mass/volume] in Blood

11187

109081

1.13

3.89

33.0

15.1

133.2

137.9

g/l

191.55

11076

107371

(3000855) Microscopic observation [Identifier] in Vaginal fluid by Gram stain

197

1458

1.34

3.82

1.6

1.5

—

(40768441) Liver Pathology biopsy report

553

1.56

3.82

1.6

1.3

—

(3011371) Neisseria gonorrhoeae DNA [Presence] in Specimen by NAA with probe detection

874

7565

1.15

3.82

2.0

1.9

—

(3043410) Blood group antigens tested for on Red Blood Cells

211

1.92

3.80

1.3

1.4

—

(3018461) Alpha 1 globulin [Mass/time] in 24 hour Urine by Electrophoresis

106

2.33

3.78

6.0

5.9

41.2

42.6

ug/min

0.05

(3013139) Helicobacter pylori Ag [Presence] in Stool

628

5305

1.18

3.77

1.2

—

(3013931) Oligosaccharides [Presence] in Urine

11.85

3.73

1.0

—

(3037441) Creatinine [Moles/volume] in Peritoneal dialysis fluid

3.75

3.72

6.8

6.1

575.5

479.9

umol/l

0.55

(42870325) Hepcidin 25 amino acid peptide [Moles/volume] in Serum or Plasma

101

2.35

3.70

1.0

1.5

3.4

219546.6

nmol/l

1.05

(3027974) Hepatitis B virus e Ag [Presence] in Serum

3.14

3.69

1.4

2.0

—

(3018251) Fasting glucose [Moles/volume] in Serum or Plasma

9069

87617

1.08

3.66

4.5

4.0

6.0

5.9

mmol/l

11.27

8326

80399

(3050238) Crystals [Presence] in Synovial fluid by Light microscopy

250

1927

1.29

3.64

1.4

—

(3001501) Glucose [Moles/volume] in Capillary blood by Glucometer

147

2.08

3.61

2.2

2.3

6.2

8.3

mmol/l

1.89

(3018851) Theophylline [Moles/volume] in Serum or Plasma

2.96

3.60

1.8

1.6

63.5

38.5

umol/l

1.21

(3040661) Urea [Moles/volume] in Peritoneal dialysis fluid

3.62

3.56

6.6

5.9

19.3

16.8

mmol/l

0.82

(3020321) Streptococcus agalactiae [Presence] in Vaginal fluid by Organism specific culture

257

3206

0.79

3.55

1.5

1.6

—

(3023091) Interleukin 6 [Mass/volume] in Serum or Plasma

122

2.19

3.55

1.7

1.5

39.1

171.4

ng/l

1.20

(40761539) Cells [Type] in Urine sediment by Light microscopy

182

1.96

3.54

1.3

1.2

—

(40766189) Gliadin peptide IgG Ab [Units/volume] in Serum by Immunoassay

325

2597

1.24

3.51

1.1

4.1

7.6

u/ml

0.99

356

(3018738) Hemoglobin F/Hemoglobin.total in Blood

2.36

3.45

2.5

2.6

14.1

6.9

—

(3045519) Venlafaxine [Moles/volume] in Serum or Plasma

3.80

3.45

1.6

1.4

398.0

657.1

nmol/l

—

(3022145) Colonoscopy Study observation

1025

9034

1.13

3.44

1.4

—

(3029075) Extractable nuclear Ab panel - Serum

205

1.88

3.43

1.1

—

(3025547) Thyroglobulin Ab [Units/volume] in Serum or Plasma

108

738

1.45

3.40

3.4

4.7

171.6

86.1

u/ml

0.43

235

(3033923) Metanephrine [Moles/time] in 24 hour Urine

125

2.14

3.36

1.0

1.1

0.7

1.2

umol/24h

0.52

(3036432) Mycobacterium tuberculosis genotype [Identifier] in Isolate

309

1.70

3.33

3.3

3.9

—

(3010838) Calcium [Moles/time] in 24 hour Urine

318

1.68

3.28

1.2

1.6

4.4

6.2

mmol/24h

—

(40761516) BRAF gene p.Val600Glu [Presence] in Tissue by Molecular genetics method

3.40

3.26

1.0

—

(36033641) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Rapid immunoassay

275

2178

1.25

3.25

1.9

1.7

—

(3015147) Influenza virus A IgG Ab [Units/volume] in Serum

8.47

3.23

1.0

—

(40768795) Lymph node Pathology biopsy report

483

1.54

3.18

1.2

1.1

—

(3050449) Albumin [Mass/time] in Urine collected for unspecified duration

254

2000

1.26

3.17

2.5

2.4

168.5

97.2

ug/min

1.34

144

1254

(3019832) Treponema pallidum Ab [Presence] in Serum

1473

13317

1.10

3.15

1.8

1.7

—

(3011831) Apolipoprotein B/Apolipoprotein A-I [Percentile]

520

0.51

3.14

1.2

1.3

—

(3014051) Protein [Presence] in Urine by Test strip

233

1818

1.27

3.14

2.2

1.9

—

(36306090) Helicobacter pylori [Presence] in Tissue by Organism specific culture

285

1.70

3.13

1.0

—

(3017704) Immunofixation for Urine

300

1.68

3.12

1.2

1.5

—

(3009876) Amylase isoenzyme 3 panel - Serum or Plasma

2.82

3.11

1.4

1.1

—

(3006571) Polymorphonuclear cells/100 leukocytes in Synovial fluid

124

885

1.39

3.10

1.6

1.5

60.2

56.5

0.49

548

(3000034) Microalbumin [Mass/volume] in Urine

102

705

1.43

3.07

3.5

3.1

139.3

61.5

mg/l

0.67

519

(3039355) Methicillin resistant Staphylococcus aureus [Presence] in Nose by Organism specific culture

2.33

3.05

2.2

1.6

—

(3033319) Streptococcus pyogenes Ag [Presence] in Throat

1105

12043

0.90

3.01

1.5

1.4

—

(3019920) Amitriptyline [Moles/volume] in Serum or Plasma

5.76

2.99

2.0

1.7

486.6

401.4

nmol/l

—

(44786800) Granulocytes/100 leukocytes in Body fluid

2.40

2.96

1.6

1.3

26.0

27.9

0.09

(3004347) Hepatitis D virus Ab [Presence] in Serum

4.23

2.95

1.1

1.0

—

(3043405) Microscopic observation [Identifier] in Specimen by Non-gynecological cytology method

637

1.44

2.95

1.2

1.4

—

(3010254) Herpes simplex virus identified in Specimen by Organism specific culture

168

1.88

2.88

1.1

—

(3034099) Cytomegalovirus Ab [Titer] in Cerebral spinal fluid

6.58

2.84

1.0

1.1

—

(3010156) C reactive protein [Mass/volume] in Serum or Plasma by High sensitivity method

315

3725

0.83

2.71

1.7

1.5

3.7

3.4

mg/l

0.29

242

2459

(21494434) Karyotype in Bone marrow

526

1.47

2.71

1.2

—

(3010144) Erythrocytes [#/volume] in Synovial fluid

650

1.42

2.68

1.3

190089.5

112896.6

e6/l

0.37

439

(3032492) JC virus DNA [#/volume] (viral load) in Cerebral spinal fluid by NAA with probe detection

5.93

2.67

1.5

1.0

—

(3003129) Base excess in Capillary blood by calculation

188

1.79

2.63

1.3

1.7

1.3

0.6

mmol/l

0.28

173

(3028371) Actinomyces sp identified in Specimen by Organism specific culture

2.47

2.62

1.1

1.0

—

(42869858) Acute and chronic leukemia fusion transcript panel - Blood or Tissue by Molecular genetics method

2.47

2.62

1.3

1.1

—

(3016616) Dehydroepiandrosterone sulfate (DHEA-S) [Moles/volume] in Serum or Plasma

646

1.41

2.59

1.4

1.2

4.3

5.7

umol/l

3.25

601

(3015822) Parvovirus B19 DNA [Presence] in Serum by NAA with probe detection

4.61

2.56

1.0

1.1

—

(1002102) Choriogonadotropin.intact+Beta subunit [Mass/volume] in Serum or Plasma

215

2618

0.81

2.51

1.5

—

(3045781) Inhibin B [Mass/volume] in Serum or Plasma

215

1.70

2.44

1.8

2.1

200.2

115.5

ng/l

0.48

138

(3013201) Beta-2-Microglobulin [Mass/volume] in Serum or Plasma

444

1.47

2.37

1.4

1.9

3.8

3.6

mg/l

0.18

425

(3049506) Microalbumin [Mass/time] in Urine collected for unspecified duration

420

1.48

2.36

1.9

2.1

136.8

100.1

ug/min

0.28

106

(3041449) Collagen crosslinked C-telopeptide [Mass/volume] in Serum or Plasma

130

1.90

2.36

1.4

1.6

0.3

0.4

ug/l

1.69

(40760871) Heparin induced platelet Ab [Presence] in Serum or Plasma by Immunoassay

3.29

2.35

1.2

1.4

—

(3017312) HC gene rearrangements [Presence] in Blood or Tissue by Molecular genetics method

4.07

2.33

1.0

—

(3037534) Parathyrin related protein [Mass/volume] in Serum or Plasma

117

1.94

2.31

1.4

1.5

144.0

129.6

ng/l

0.12

117

(4034850)

318

2658

1.19

2.30

12.1

8.2

—

(3020013) Alkaline phosphatase.intestinal [Enzymatic activity/volume] in Serum or Plasma

415

1.48

2.29

1.5

10.0

5.6

u/l

0.81

194

(3042010) Triglyceride [Moles/volume] in Pleural fluid

2.04

2.29

1.3

0.3

1.6

mmol/l

1.24

(40768800) Prostate Pathology biopsy report

153

1908

0.79

2.25

1.1

1.2

—

(3036670) Protein [Mass/volume] in Synovial fluid

198

1.70

2.25

1.3

1.2

38.5

40.2

g/l

0.17

108

(40758990) Choriogonadotropin.beta subunit [Mass/volume] in Serum or Plasma

310

0.48

2.25

1.3

1.2

—

(3020491) Glucose [Moles/volume] in Blood

673

1.37

2.24

1.9

1.8

7.0

6.5

mmol/l

0.53

488

(3016135) IgD [Mass/volume] in Serum

4.56

2.24

7.3

1.1

93.2

155.0

mg/l

—

(3024263) Appearance of Synovial fluid

394

1.48

2.21

1.9

1.8

—

(3009347) Lactate dehydrogenase isoenzymes [Interpretation] in Serum or Plasma

3.07

2.19

1.0

1.1

—

(3041918) Cholesterol [Moles/volume] in Pleural fluid

120

1.89

2.17

1.3

1.2

1.3

1.8

mmol/l

1.26

(3024172) Erythropoietin (EPO) [Units/volume] in Serum or Plasma

153

1196

1.27

2.15

1.3

30.0

28.0

u/l

0.11

129

1032

(3023919) Lactate dehydrogenase 2/Lactate dehydrogenase.total in Serum or Plasma by Electrophoresis

3.29

2.15

1.0

1.1

33.3

37.1

—

(3024830) Lactate dehydrogenase 4/Lactate dehydrogenase.total in Serum or Plasma by Electrophoresis

3.29

2.15

1.0

11.7

8.5

—

(3007858) Lactate dehydrogenase 3/Lactate dehydrogenase.total in Serum or Plasma by Electrophoresis

3.29

2.15

1.0

1.1

19.9

21.5

—

(3036048) Francisella tularensis Ab [Titer] in Serum

142

1.81

2.14

1.1

1.2

—

400.0

—

(3051252) Vasoactive intestinal peptide [Moles/volume] in Serum or Plasma

2.47

2.12

1.8

1.4

19.4

21.1

pmol/l

0.08

(3013166) Neutrophils/100 leukocytes in Synovial fluid

202

1.66

2.11

1.3

51.6

53.8

0.12

175

(3011391) Calcitriol [Moles/volume] in Serum or Plasma

572

1.38

2.10

1.2

—

(3014300) Beta 2 glycoprotein 1 IgM Ab [Units/volume] in Serum

180

1.70

2.09

1.2

—

(3017937) Magnesium [Moles/time] in 24 hour Urine

3.16

2.06

1.5

1.2

—

(3034603) RHD gene allele [Genotype] in Blood or Tissue by Molecular genetics method Nominal

948

0.72

2.05

1.4

1.5

—

(40762887) Creatinine [Moles/volume] in Blood

4.94

2.05

1.4

—

(3019768) Coxiella burnetii Ab [Presence] in Serum

2.87

2.04

1.0

1.1

—

(3020876) Protein [Mass/time] in 24 hour Urine

627

1.36

2.02

1.7

2.0

0.4

1.4

g/24h

—

(3020618) Glucose [Moles/volume] in Synovial fluid

3.95

2.01

1.0

5.0

5.7

mmol/l

—

(3000012) Reticulocyte production index

380

1.46

1.98

2.0

1.4

—

(4094501)

181

2179

0.82

1.97

1.1

—

(3032743) Legionella sp IgG Ab [Presence] in Serum

2.60

1.96

1.0

—

(3020123) Porphyrins [Interpretation] in Serum or Plasma

2.60

1.96

1.1

—

(3000285) Sodium [Moles/volume] in Blood

2.02

1.94

1.1

—

(3013293) Extractable nuclear Ab [Presence] in Serum

104

1.90

1.93

1.7

1.8

—

(4133840)

304

0.52

1.91

1.1

—

(3050794) Legionella sp Ab [Presence] in Serum

2.32

1.89

1.1

—

(3012494) Peanut IgE Ab [Units/volume] in Serum

392

1.44

1.89

1.1

1.2

152.7

19.4

u/ml

0.43

257

(21494429) FMR1 gene CGG repeat analysis in Blood or Tissue by Molecular genetics method

2.00

1.89

1.0

—

(3011951) Aspergillus fumigatus IgE Ab [Units/volume] in Serum

567

1.36

1.89

1.3

0.4

1.0

u/ml

0.96

219

(3001820) Epstein Barr virus nuclear Ab [Presence] in Serum

2.53

1.87

1.1

—

(3047166) Epithelial cells [#/area] in Urine sediment by Automated count

1.93

1.83

4.4

2.2

0.3

0.5

u/field

0.76

(3004616) Nuclear Ab [Presence] in Serum

107

820

1.29

1.81

1.4

1.3

—

(21493619) Chromosome 12 trisomy and chromosome region 11q22.3 and 13q14 and 17p13.1 deletion in Blood or Tissue by FISH

3.49

1.81

1.2

1.3

—

(3035401) Herpes virus 6 DNA [Presence] in Specimen by NAA with probe detection

3.49

1.81

7.0

1.1

—

(3026725) Estradiol (E2) [Moles/volume] in Serum or Plasma

187

1528

1.21

1.81

1.6

1.5

0.3

0.4

nmol/l

3.90

147

1246

(40763641) Cell count and Differential panel - Peritoneal dialysis fluid

4.12

1.80

4.0

2.8

—

(3036604) Creatine kinase isoenzymes [Interpretation] in Serum or Plasma by Electrophoresis

2.36

1.80

1.3

1.2

—

(3041423) Sjogrens syndrome-A extractable nuclear 60kD Ab [Units/volume] in Serum

505

1.37

1.79

1.2

61.8

48.9

u/ml

—

(3015401) Amylase [Enzymatic activity/volume] in Pleural fluid

2.00

1.79

1.4

1.3

30.5

493.3

u/l

0.71

(1617658) Protocol used for examination of sentinel lymph nodes

457

0.63

1.77

1.0

1.1

—

(40763480) Human metapneumovirus Ag [Presence] in Specimen

3.01

1.77

1.9

1.4

—

(3013180) HIV 1 RNA [Units/volume] (viral load) in Serum or Plasma by Probe with amplification

431

1.40

1.77

7.4

6.2

4054.1

7844.8

u/ml

0.21

(43534046) Estradiol (E2) [Moles/volume] in Serum or Plasma by High sensitivity method

213

1.58

1.76

1.9

1.5

0.2

nmol/l

0.08

150

(3021578) Parainfluenza virus 2 Ag [Presence] in Specimen

167

1.66

1.75

1.3

1.1

—

(3005880) Parainfluenza virus 3 Ag [Presence] in Specimen

167

1.66

1.75

1.3

1.1

—

(3041067) Sjogrens syndrome-A extractable nuclear 52kD Ab [Units/volume] in Serum

508

1.36

1.73

1.2

71.4

43.8

u/ml

—

(43055089) Myosin Ab [Presence] in Serum or Plasma by Immunoblot

318

1.46

1.72

1.0

1.1

—

(40768443) Skin Pathology biopsy report

397

3465

1.14

1.71

1.2

—

(21494567) Legionella sp IgM Ab [Presence] in Serum

2.41

1.70

1.0

—

(3026515) Parvovirus B19 IgM Ab [Units/volume] in Serum

426

1.39

1.70

1.1

1.2

—

(3016628) Fibrinogen Ag [Mass/volume] in Platelet poor plasma by Immunoassay

139

1.71

1.68

1.3

1.2

0.5

48.7

mg/l

0.71

102

(3029511) Human papilloma virus DNA [Presence] in Specimen by NAA with probe detection

229

2649

0.85

1.66

1.6

1.4

—

(3021367) Citalopram [Moles/volume] in Serum or Plasma

3.12

1.64

1.5

1.4

165.7

117.2

nmol/l

—

(42529582) MDA5 Ab [Presence] in Serum by Line blot

148

1.67

1.62

1.0

1.1

—

(42529598) SUMO-activating enzyme subunit 1 Ab [Presence] in Serum by Line blot

148

1.67

1.62

1.0

1.1

—

(3013637) Mi-2 Ab [Presence] in Serum

148

1.67

1.62

1.0

1.1

—

(42528593) TIF1-gamma Ab [Presence] in Serum by Line blot

148

1.67

1.62

1.0

1.1

—

(40761873) Peanut recombinant (rAra h) 1 IgE Ab [Units/volume] in Serum

133

1.71

1.62

1.0

1.1

0.2

4.1

u/ml

0.80

(3010657) Triiodothyronine (T3) Free [Mass/volume] in Serum or Plasma by Dialysis

2.77

1.62

1.0

1.3

—

(43054914) Glucose tolerance 2 hours panel - Serum or Plasma

1004

10647

0.92

1.61

1.7

1.8

—

(3014043) Spermatozoa Nonprogressive/100 spermatozoa in Semen

421

0.63

1.60

4.7

6.6

—

(3046861) Legionella sp Ag [Presence] in Urine

2.96

1.56

1.0

1.1

—

(3006270) Folate [Moles/volume] in Blood

656

1.30

1.55

1.1

354.4

373.8

nmol/l

0.36

573

(3000213) Normetanephrine [Moles/time] in 24 hour Urine

2.04

1.54

1.0

1.2

1.8

1.9

umol/24h

0.09

(3019174) dRVVT (LA screen)

1.98

1.53

1.1

1.2

—

(3043109) Cytology report of Tissue fine needle aspirate Cyto stain

196

1641

1.18

1.51

1.3

1.2

—

(3010464) Parainfluenza virus 1 Ag [Presence] in Specimen

167

1.60

1.50

1.3

1.1

—

(3009550) Parvovirus B19 IgG Ab [Titer] in Serum

370

1.39

1.49

1.1

1.3

—

(3022058) Hepatitis B virus DNA [Presence] in Serum or Plasma by NAA with probe detection

176

1.57

1.47

1.1

1.2

—

(3011897) Casein IgE Ab [Units/volume] in Serum

256

1.47

1.46

1.4

29.9

6.8

u/ml

0.59

(36305771) Cryptosporidium sp DNA [Presence] in Stool by NAA with probe detection

525

1.32

1.45

1.3

1.2

—

(3045424) Erythrocytes [Presence] in Urine

166

1376

1.19

1.45

1.3

1.4

—

(40761995) Spermatozoa Progressive [#/volume] in Semen

421

0.66

1.44

2.3

3.3

—

(3034274) Bile acid [Moles/volume] in Serum --fasting

180

1505

1.18

1.43

2.2

2.3

9.5

6.9

umol/l

0.65

137

1111

(42870298) TPMT gene c.238G>C+460G>A+719A>G [Identifier] in Blood or Tissue by Molecular genetics method Narrative

117

1.69

1.38

1.1

1.0

—

(3005136) Cladosporium herbarum IgE Ab [Units/volume] in Serum

116

1398

0.82

1.38

1.1

1.2

0.4

u/ml

0.43

368

(42869547) Procollagen type III.N-terminal propeptide [Mass/volume] in Serum

211

1.50

1.38

1.5

1.6

11.4

8.8

ug/l

1.12

211

(3002621) Streptococcal DNAse B [Units/volume] in Serum

1.77

1.37

1.0

1.1

—

(3014591) Smooth Alder IgE Ab [Units/volume] in Serum

0.00

1.34

0.0

1.0

—

(3038177) Helicobacter pylori Ab [Presence] in Serum

177

1488

1.18

1.34

1.2

—

(40766207) Peanut recombinant (rAra h) 8 IgE Ab [Units/volume] in Serum

1.78

1.32

1.1

24.9

11.7

u/ml

—

(3023530) 17-Hydroxyprogesterone [Moles/volume] in Serum or Plasma

104

1.71

1.31

1.8

2.0

2.9

5.0

nmol/l

0.45

(3021513) Carbon dioxide [Partial pressure] in Mixed venous blood

222

1.47

1.30

9.5

6.5

—

(44816893) Food Allergen Mix 50 (Kiwi+Pineapple+Banana+Mango) IgE Ab [Units/volume] in Serum by Multidisk

327

0.63

1.29

1.0

—

(3000492) Spirometry study

981

9089

1.07

1.29

1.5

1.4

—

(3021236) Streptolysin O Ab [Units/volume] in Serum or Plasma

381

1.35

1.29

1.1

238.5

199.9

iu/ml

0.23

381

(21494670) JAK2 gene exon 14 targeted mutation analysis in Blood or Tissue by Molecular genetics method

115

933

1.22

1.29

1.1

—

(40761545) Erythrocytes.dysmorphic [Presence] in Urine sediment by Light microscopy

2.01

1.28

1.1

—

(3005082) Progesterone [Moles/volume] in Serum or Plasma

672

0.75

1.28

1.2

1.4

29.0

31.8

nmol/l

0.31

625

(3003932) Carbon dioxide [Partial pressure] in Arterial cord blood

183

1.51

1.27

1.0

7.1

7.3

kpa

0.25

157

(3004959) Base excess in Arterial cord blood by calculation

183

1.51

1.27

1.0

-2.6

-2.1

mmol/l

—

(3006598) pH of Arterial cord blood

183

1.51

1.27

1.0

—

(40761871) Peanut recombinant (rAra h) 3 IgE Ab [Units/volume] in Serum

136

1.60

1.26

1.0

1.1

0.1

0.5

u/ml

1.07

(3014133) Dog dander IgE Ab [Units/volume] in Serum

152

1768

0.85

1.26

1.1

5.6

5.0

u/ml

0.12

791

(40771527) Human papilloma virus E6+E7 mRNA [Presence] in Cervix by NAA with probe detection

307

1.38

1.25

1.8

2.0

—

(40767665) Peanut recombinant (rAra h) 9 IgE Ab [Units/volume] in Serum

121

1.63

1.25

1.0

1.1

0.4

u/ml

0.03

(3034891) Synovial lining cells/100 cells in Synovial fluid

341

1.36

1.24

1.7

1.4

3.6

3.7

0.00

(3007916) DNA double strand Ab [Titer] in Serum

1.86

1.24

1.4

—

291.7

—

(3045683) HLA typing for celiac disease panel - Blood or Tissue

574

1.27

1.24

1.0

—

(3001334) Neutrophil cytoplasmic Ab [Units/volume] in Serum

2.06

1.23

1.2

1.0

—

(3004446) Plasmodium sp identified in Blood by Light microscopy

1.91

1.23

2.2

2.3

—

(40757578) FLT3 gene targeted mutation analysis in Bone marrow by Molecular genetics method

2.60

1.20

1.0

1.1

—

(3021706) Oxygen [Partial pressure] in Arterial cord blood

178

1.50

1.19

1.0

3.3

3.5

kpa

0.16

151

(3001729) Color of Synovial fluid

1.94

1.18

1.5

1.6

—

(3027570) Oxalate [Moles/time] in 24 hour Urine

1.94

1.18

1.4

317.1

326.7

umol/24h

0.05

(3014064) Pregnancy associated plasma protein A [Multiple of the median] in Serum or Plasma

124

0.48

1.16

1.0

1.1

—

(40768793) Breast Pathology biopsy report

122

1434

0.84

1.16

1.4

1.3

—

(3000924) Streptococcus pyogenes [Presence] in Throat by Organism specific culture

190

1631

1.15

1.14

1.3

—

(3027901) Hemoglobin [Mass/volume] in Arterial cord blood

1.72

1.14

1.0

172.7

164.1

g/l

1.09

(3007625) Streptococcus pneumoniae Ag [Presence] in Specimen

2.47

1.13

1.0

1.5

—

(3012413) Glucose [Moles/volume] in Serum or Plasma --2 hours post meal

110

903

1.20

1.13

1.4

11.5

12.0

mmol/l

0.27

189

(3025315) Body weight

1.91

1.13

3.9

3.5

—

(3015183) Erythrocyte sedimentation rate

510

0.73

1.11

1.2

1.1

—

(37020937) Giardia lamblia DNA [Presence] in Stool by NAA with probe detection

524

1.26

1.08

1.3

1.2

—

(3023430) Cat dander IgE Ab [Units/volume] in Serum

142

1631

0.86

1.05

1.1

9.3

6.1

u/ml

0.38

754

(3020650) Glucose [Presence] in Urine

261

0.64

1.03

1.2

1.4

—

(40763091) Bacteria identified in Peritoneal dialysis fluid by Culture

1.89

1.01

6.1

3.1

—

(3041008) Bicarbonate [Moles/volume] standard in Arterial cord blood

219

1.40

1.00

1.2

1.1

20.3

20.0

mmol/l

0.20

202

(36032269) Testosterone Free [Moles/volume] in Serum or Plasma by calculation

271

2407

1.11

0.99

2.0

1.8

196.4

199.3

pmol/l

0.14

262

2288

(3016750) Collection duration of Urine

478

1.26

0.99

2.5

2.2

500.2

496.5

min

0.10

373

(3036603) Volume of Urine

453

1.27

0.97

1.4

1.7

1721.9

2052.0

1.33

107

(3035933) Granulocytes/100 leukocytes in Blood

297

1.33

0.97

1.6

1.4

—

(3016701) Glucose [Moles/volume] in Serum or Plasma --2 hours post dose glucose

122

1404

0.86

0.95

1.3

1.4

7.2

7.1

mmol/l

0.21

992

(44813793)

686

1.21

0.95

1.1

—

(4146454)

101

840

1.19

0.94

3.1

2.8

—

(3007302) Hemoglobin [Mass/volume] in Mixed venous blood

1.74

0.93

13.0

6.3

—

(3002256) Pathology report gross observation

1133

10674

1.05

0.92

1.3

—

(3041806) Other cells [#/volume] in Blood by Manual count

745

0.81

0.91

1.6

1.4

—

(723473) SARS-CoV-2 (COVID-19) IgA Ab [Presence] in Serum or Plasma by Immunoassay

1.93

0.89

1.9

1.1

—

(3004775) Volume in Urine collected for unspecified duration

656

1.21

0.88

2.5

2.3

704.5

636.8

0.80

460

(3028009) Chlamydia trachomatis IgG Ab [Units/volume] in Serum

128

0.54

0.87

1.0

—

(3047007) Chlamydophila sp Ab [Presence] in Serum

151

1307

1.14

0.87

1.2

—

(1175715) Chlamydophila pneumoniae IgM Ab [Presence] in Serum by Immunoassay

151

1307

1.14

0.87

1.1

—

(40765096) Chromosome analysis panel by Banding

143

1.45

0.84

1.4

1.1

—

(3025577) Chromium [Mass/volume] in Blood

452

0.76

0.84

1.9

2.0

1.7

2.2

ug/l

0.82

375

(3010726) Horse dander IgE Ab [Units/volume] in Serum

195

2150

0.89

0.84

1.1

2.8

u/ml

0.01

627

(3014891) Appearance of Pleural fluid

1.70

0.82

1.5

—

(3011841) English Walnut IgE Ab [Units/volume] in Serum

169

1.40

0.82

1.1

4.4

8.6

u/ml

0.42

140

(42528717) Cashew nut recombinant (rAna o) 3 IgE Ab [Units/volume] in Serum

169

1.40

0.82

1.0

1.1

5.3

4.0

u/ml

0.15

138

(3036071) Salmonella sp Ab [Titer] in Serum

280

1.31

0.82

1.1

—

(3044009) aPTT.lupus sensitive (LA screen)

1.65

0.81

1.2

—

(4212803)

1.73

0.80

1.1

1.0

—

(43055246) Days in therapeutic INR range/Days INR result determined [Ratio]

137

1.44

0.79

4.2

6.7

63.2

73.1

0.67

108

(3042206) Streptococcus agalactiae Ag [Presence] in Vaginal fluid

160

1777

0.89

0.79

1.2

—

(37020300) Entamoeba histolytica DNA [Presence] in Stool by NAA with probe detection

300

1.28

0.77

1.3

1.2

—

(44806420)

196

0.65

0.77

2.2

2.3

—

(3022689) Creatine [Moles/volume] in Urine

240

1.32

0.76

1.6

1.5

—

(3037551) Cancer Ag 125 [Units/volume] in Serum or Plasma

365

3345

1.08

0.75

2.9

124.1

49.2

u/ml

0.45

355

3227

(3038071) Oxygen [Partial pressure] in Mixed venous blood

198

1.35

0.74

10.1

6.5

—

(3035457) Cefaclor IgE Ab [Units/volume] in Serum

1.59

0.71

1.0

1.1

—

(3035062) Alkaline phosphatase.liver 1 [Enzymatic activity/volume] in Serum or Plasma

343

1.24

0.66

1.0

1.1

89.6

78.1

u/l

0.65

279

(3036185) Alkaline phosphatase.liver 2 [Enzymatic activity/volume] in Serum or Plasma

343

1.24

0.66

1.0

1.1

24.0

20.0

u/l

0.25

266

(3025130) Human papilloma virus identified in Specimen

131

1150

1.13

0.66

1.8

1.7

—

(40766183) Gliadin peptide IgA Ab [Units/volume] in Serum by Immunoassay

123

1368

0.89

0.66

1.1

2.1

4.2

u/ml

2.73

679

(3037556) Urate [Mass/volume] in Serum or Plasma

245

0.72

0.65

1.7

1.4

—

(3051101) Glucose [Moles/volume] in Cord blood

152

0.65

0.64

4.3

6.4

—

(3020934) Sesame Seed IgE Ab [Units/volume] in Serum

0.00

0.60

0.0

1.0

—

7.1

—

(3008898) HLA-B27 [Presence]

344

3180

1.07

0.60

1.1

—

(3040794) Aluminum [Moles/volume] in Urine

0.00

0.59

0.0

1.2

—

(3013762) Body weight Measured

1.74

0.58

1.3

1.1

—

(3027955) HFE gene mutations tested for in Blood or Tissue by Molecular genetics method Nominal

113

1.40

0.57

1.1

1.0

—

(3012215) Mononuclear cells/100 leukocytes in Synovial fluid

191

1.29

0.56

1.2

1.3

36.0

40.1

0.20

121

(3020356) Listeria sp identified in Specimen by Organism specific culture

1.54

0.56

1.1

1.2

—

(3015076) Soybean IgE Ab [Units/volume] in Serum

658

0.85

0.55

1.2

1.1

1.2

0.7

u/ml

0.40

125

(3002670) Multiple inhalant allergen IgE Ab [Units/volume] in Serum

544

1.16

0.54

1.8

2.0

—

(3016273) Islet cell 512 Ab [Units/volume] in Serum

106

1.40

0.54

1.1

1.0

—

(3011335) Digoxin [Mass/volume] in Serum or Plasma

1.56

0.53

1.7

2.2

—

(3005411) Squamous cell carcinoma Ag [Mass/volume] in Serum or Plasma

145

0.68

0.53

1.1

1.9

2.3

ug/l

—

(4281824)

694

1.14

0.52

1.2

1.1

—

(3053028) Streptococcus sp identified in Specimen by Organism specific culture

547

1.16

0.52

1.4

1.3

—

(3005011) Chlamydia sp Ab [Titer] in Serum

142

1.32

0.50

1.2

1.5

—

(1002224) Polysomnography panel

387

4029

0.95

0.49

1.1

—

(44806071)

117

1.35

0.49

1.2

1.1

—

(3015024) Glucose [Moles/volume] in Serum or Plasma --1 hour post dose glucose

1004

0.89

0.48

1.5

1.6

7.6

mmol/l

0.04

601

(42868766) Dientamoeba fragilis DNA [Presence] in Stool by NAA with probe detection

241

1.23

0.47

1.4

1.2

—

(40761872) Peanut recombinant (rAra h) 2 IgE Ab [Units/volume] in Serum

286

1.21

0.47

1.1

1.2

2.8

12.5

u/ml

1.72

222

(3029715) Chromosome analysis.interphase [Interpretation] in Bone marrow by FISH Narrative

110

1.35

0.45

1.4

1.1

—

(3027035) Albumin [Mass/time] in 24 hour Urine

1.43

0.45

1.5

1.2

—

417.9

—

(4211845)

445

1.15

0.43

2.6

2.8

—

(3031067) HIV 1 p24 Ag [Mass/volume] in Serum or Plasma by Immunoassay

1.59

0.42

1.0

—

(3018006) Microscopic observation [Identifier] in Cervix by Cyto stain.thin prep

1338

13535

0.97

0.42

1.5

—

(3046426) Aquaporin 4 water channel IgG Ab [Presence] in Serum or Plasma

147

1.28

0.41

1.1

—

(3006969) Lambda light chains [Mass/volume] in Urine

0.00

0.41

0.0

1.1

—

0.0

—

(3022670) pH of Venous cord blood

1.34

0.40

1.0

—

(40758292) HTLV I+II Ab panel - Serum

139

1.28

0.40

1.3

1.4

—

(3044316) Mercury [Moles/volume] in Urine

0.00

0.40

0.0

2.2

—

7.2

—

(3027505) Alpha-1-Fetoprotein [Units/volume] in Amniotic fluid

0.00

0.40

0.0

1.0

—

(3002523) Influenza virus A Ag [Presence] in Specimen

163

1725

0.93

0.38

1.2

1.1

—

(3003740) Influenza virus B Ag [Presence] in Specimen

163

1724

0.93

0.38

1.2

1.1

—

(37020271) Myelin oligodendrocyte glycoprotein Ab [Titer] in Serum by Cell binding immunofluorescent assay

1.35

0.37

1.0

1.2

—

(44786774) Adalimumab [Mass/volume] in Serum or Plasma

341

1.16

0.37

2.4

2.1

8.1

9.8

mg/l

1.21

284

(3006462) Nitrate [Presence] in Urine

406

1.14

0.37

2.5

2.9

—

(3023351) European house dust mite IgE Ab [Units/volume] in Serum

240

2501

0.95

0.36

1.2

1.1

2.2

2.1

u/ml

0.07

124

1163

(3026048) Bordetella pertussis IgG Ab [Units/volume] in Serum

197

1.20

0.34

1.0

1.1

—

(3013466) aPTT in Blood by Coagulation assay

1.35

0.34

1.2

1.1

40.9

38.4

—

(3016845) Adenovirus Ag [Presence] in Specimen by Immunofluorescence

290

1.16

0.32

1.3

1.1

—

(3034037) Hematocrit [Volume Fraction] of Mixed venous blood

144

1.23

0.32

8.7

6.7

—

(3025018) Bordetella pertussis Ab [Titer] in Serum

571

1.11

0.32

1.2

—

(3027231) Wheat IgE Ab [Units/volume] in Serum

255

1.16

0.30

1.3

1.1

—

1.9

—

(3014444) EGFR gene mutations tested for in Blood or Tissue by Molecular genetics method Nominal

1.28

0.30

1.1

—

(723474) SARS-CoV-2 (COVID-19) IgG Ab [Presence] in Serum or Plasma by Immunoassay

182

1.19

0.30

1.5

1.1

—

(3047189) Immunofixation for 24 hour Urine

285

1.14

0.28

1.4

1.7

—

(3041672) Baker's yeast Ab [Presence] in Serum

1.30

0.28

1.0

1.1

—

(3016031) Almond IgE Ab [Units/volume] in Serum

102

1.26

0.27

1.0

1.5

1.3

u/ml

—

(3038769) Chlamydophila pneumoniae IgG Ab [Units/volume] in Serum by Immunoassay

223

0.84

0.27

1.0

1.1

41.0

58.0

u/ml

0.77

217

(3028334) Neisseria gonorrhoeae [Presence] in Specimen by Organism specific culture

277

1.14

0.26

1.9

1.8

—

(3017962) TCRG gene rearrangements [Presence] in Blood or Tissue by Molecular genetics method

1.22

0.26

1.4

—

(3001556) Androgen free Index in Serum or Plasma

130

1.22

0.26

1.4

1.2

—

(1002183) Plasma cells monotypic population [Identifier] in Bone marrow by Flow cytometry (FC)

0.67

0.25

1.2

—

(3010937) Rubella virus Ab [Presence] in Serum

1.25

0.25

1.1

—

(3045209) Lutropin/Follitropin [Ratio] in Serum or Plasma

188

0.84

0.23

1.5

1.2

—

(3047826) Mullerian inhibiting substance [Mass/volume] in Serum or Plasma

161

1666

0.95

0.23

1.3

3.2

4.1

ug/l

1.81

148

1553

(3011325) HIV 1+2 Ab [Presence] in Serum

1.27

0.22

1.0

1.1

—

(3034092) Cytoplasmic Ig cells/100 cells in Blood

133

0.82

0.21

10.3

6.1

—

(3027859) Formaldehyde IgE Ab [Units/volume] in Serum

0.00

0.21

0.0

1.0

—

(3012138) Guinea pig epithelium IgE Ab [Units/volume] in Serum

0.00

0.21

0.0

1.0

—

0.9

—

(3051596) Benzodiazepines [Presence] in Serum or Plasma by Screen method

0.00

0.20

0.0

1.0

—

(3004915) Chlamydophila pneumoniae IgA Ab [Units/volume] in Serum

665

1.07

0.20

1.0

1.1

—

(3008401) Mugwort IgE Ab [Units/volume] in Serum

210

2150

0.96

0.20

1.1

1.3

u/ml

0.19

102

1078

(3003888) Timothy IgE Ab [Units/volume] in Serum

219

2240

0.96

0.19

1.1

7.4

7.0

u/ml

0.10

121

1309

(40762482) Peach recombinant (rPru p) 3 IgE Ab [Units/volume] in Serum

1.19

0.18

1.0

0.2

0.4

u/ml

—

(3051387) C reactive protein [Mass/volume] in Capillary blood

204

1959

1.03

0.14

3.6

2.9

26.9

27.6

mg/l

0.10

123

1237

(1175556) inFLIXimab Ab [Units/volume] in Serum by Immunoassay

413

0.93

0.13

2.6

3.3

97.3

123.1

au/ml

—

(36032419) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Immunoassay

404

4063

0.98

0.13

1.9

—

(3002067) Lambda light chains [Mass/time] in 24 hour Urine

106

0.84

0.13

1.2

3.1

—

(3032868) Hemoglobin electrophoresis panel in Blood

107

0.83

0.13

1.4

1.6

—

(3025378) Microscopic observation [Identifier] in Cervix by Cyto stain

122

1.13

0.11

1.3

1.1

—

(42868674) Cholesterol in HDL/Cholesterol.total [Molar ratio] in Serum or Plasma

1041

10192

1.01

0.10

4.2

4.1

32.3

32.0

0.49

766

6985

(3022475) Manganese [Moles/volume] in Blood

1.12

0.10

1.0

1.6

—

(40760435) Tropomyosin IgE Ab [Units/volume] in Serum

123

0.88

0.09

1.2

1.0

—

(3009871) Measles virus Ab [Titer] in Serum

285

0.94

0.09

1.9

1.7

—

(1175825) Sexually transmitted pathogens panel - Specimen by NAA with probe detection

1.12

0.09

1.3

1.2

—

(3048879) Bone marrow aspiration report

163

1.09

0.08

1.3

2.0

—

(40767663) Brazil Nut recombinant (rBer e) 1 IgE Ab [Units/volume] in Serum

122

0.89

0.08

1.0

1.1

—

(3012741) Chlamydophila pneumoniae IgA Ab [Titer] in Serum

1.05

0.07

1.0

1.1

—

(3004248) Sex hormone binding globulin [Moles/volume] in Serum or Plasma

361

3606

0.99

0.07

1.9

1.7

44.8

40.3

nmol/l

1.91

352

3521

(46235168) Fasting glucose [Moles/volume] in Blood

140

0.92

0.06

1.5

1.2

7.2

7.8

mmol/l

—

(3025149) Bordetella pertussis IgA Ab [Units/volume] in Serum

614

1.03

0.06

1.0

1.1

20.0

7.6

iu/ml

1.43

151

(3025443) Phadiatop IgE Ab [Units/volume] in Serum

409

0.97

0.05

1.0

1.1

22.8

10.0

u/ml

—

(3014599) Egg white IgE Ab [Units/volume] in Serum

727

0.98

0.04

1.2

1.1

10.0

6.7

u/ml

0.14

239

(4015189)

178

0.94

0.04

1.5

2.1

—

(3050380) Cytology report of Cervical or vaginal smear or scraping Cyto stain

279

2737

1.01

0.03

1.4

—

(3020874) Milk IgE Ab [Units/volume] in Serum

752

0.98

0.02

1.2

9.3

3.8

u/ml

0.38

284

(3048522) Glucose [Moles/volume] in Serum or Plasma --pre dose glucose

125

0.95

0.01

1.2

1.3

—

(3036535) Thyroglobulin [Mass/volume] in Serum or Plasma

447

1.02

0.01

6.2

6.9

—

(3029396) Erythrocyte agglutination [Presence] in Blood

349

1.02

0.01

2.6

2.9

—

(4038314)

111

0.98

0.00

1.2

—

(3019497) Choriogonadotropin.beta subunit free [Moles/volume] in Serum or Plasma

632

1.00

0.00

2.4

2.0

—

(3042299) inFLIXimab [Mass/volume] in Serum or Plasma

446

1.00

0.00

3.1

4.1

8.3

8.2

mg/l

0.02

361

(40765089) Chromosome analysis panel - Blood by G-banded

506

1.00

0.00

1.0

—

(1175553) Vedolizumab and Vedolizumab Ab panel [Mass/volume] - Serum or Plasma

1.01

0.00

4.5

3.5

—

(44816752) ERBB2 gene copy number/nucleus in Tissue by FISH

294

1.01

0.00

1.1

—

(40760087) Plasmodium sp Ab [Presence] in Serum by Immunofluorescence

0.00

0.0

1.1

—

(3044590) Delta aminolevulinate [Moles/volume] in Urine

0.00

0.0

1.0

—

16.0

—

(3014178) Parietal cell Ab [Units/volume] in Serum

0.00

0.0

1.0

—

(3042391) t(9;22)(q34.1;q11)(ABL1,BCR) e1a2 fusion transcript/control transcript [# Ratio] in Blood or Tissue by Molecular genetics method

0.90

0.00

9.0

5.7

—

(40761593) Coagulation factor VIII Ab [Presence] in Platelet poor plasma by Immunoassay

0.00

0.0

2.1

—

(3030940) RBC casts [#/area] in Urine by Computer assisted method

0.00

0.0

1.1

—

(3045759) Histamine [Moles/volume] in Serum or Plasma

0.00

0.0

1.4

—

(3000876) Codfish IgE Ab [Units/volume] in Serum

0.00

0.0

1.0

—

(3036005) Urine sediment comments by Light microscopy Narrative

0.00

0.0

1.4

—

(3028917) Waxy casts [#/area] in Urine by Computer assisted method

0.00

0.0

1.1

—

Mortality – FinRegistry

↥

This endpoint is excluded from FinRegistry analyses (omitted endpoint).

Relationships between endpoints

↥

Index endpoint: R18_CONVU_NOT_ELSEW_CLASSIFIED – Convulsions, not elsewhere classified

GWS hits: -

This endpoint is excluded from FinRegistry analyses (omitted endpoint).

≡ Risteys

FG R12 + FR

FinnGen R11 + FinRegistry

FinnGen R10 + FinRegistry

FinnGen R10

FinnGen R9

FinnGen R8

FinnGen R7

FinnGen R6

FinnGen R5

FinnGen R4

FinnGen R3

Convulsions, not elsewhere classified

Endpoint definition

Endpoint definition steps

FinnGen

Phenotype data

1. Apply sex-specific rule

2. Check conditions

3. Check pre-conditions, main-only, mode, registry filters

4. Check minimum number of events

5. Include endpoints

6. Filter based on genotype QC (FinnGen only)

All original rules

Similar endpoints

Case counts by codes

Upset plot

Case counts by code for Convulsions, not elsewhere classified (R18_CONVU_NOT_ELSEW_CLASSIFIED)

Summary Statistics

-FinRegistry-

-FinnGen-

Key figures

-FinnGen-

Age distribution of first events

-FinnGen-

Year distribution of first events

-FinnGen-

Cumulative Incidence Function

CodeWAS (R11)

Matched cohort

LabWAS

Mortality – FinRegistry

Relationships between endpoints